Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Review

Page Path
HOME > Article category > Review
298 Review
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Reviews
Clinical Diabetes & Therapeutics
Effects of Omega-3 Supplementation on Adipocytokines in Prediabetes and Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Tarik Becic, Christian Studenik
Diabetes Metab J. 2018;42(2):101-116.   Published online April 19, 2018
DOI: https://doi.org/10.4093/dmj.2018.42.2.101
  • 7,855 View
  • 60 Download
  • 16 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   
Background

The objective of this systematic review and meta-analysis was to determine the effects of omega-3 supplementation on adipocytokine levels in adult prediabetic and diabetic individuals.

Methods

We searched PubMed, Medline, EMBASE, Scopus, Web of Science, Google Scholar, Cochrane Trial Register, World Health Organization Clinical Trial Registry Platform, and Clinicaltrial.gov Registry from inception to August 1, 2017 for randomized controlled trials. Pooled effects of interventions were assessed as mean difference using random effects model. We conducted a sensitivity, publication bias and subgroup analysis.

Results

Fourteen studies individuals (n=685) were included in the meta-analysis. Omega-3 supplementation increased levels of adiponectin (0.48 µg/mL; 95% confidence interval [CI], 0.27 to 0.68; P<0.00001, n=10 trials), but effects disappeared after sensitivity analysis. Tumor necrosis factor α (TNF-α) levels were reduced (−1.71; 95% CI, −3.38 to −0.14; P=0.03, n=8 trials). Treatment duration shorter than 12 weeks was associated with greater reduction than longer treatment duration. Levels of other adipocytokines were not significantly affected. Publication bias could generally not be excluded.

Conclusion

Eicosapentaenoic acid and docosahexaenoic acid supplementation may increase adiponectin and reduce TNF-α levels in this population group. However, due to overall study heterogeneity and potential publication bias, a cautious interpretation is needed.

Citations

Citations to this article as recorded by  
  • The Effects of Omega-3 Fatty Acid Supplementation on the Lipid Profile and Cardiovascular Markers Following Downhill Running in Long-Distance Runners
    Marzena Jaworska, Szymon Siatkowski, Aleksandra Żebrowska
    Journal of Human Kinetics.2023; 89: 123.     CrossRef
  • Omega-3 supplementation in the treatment of polycystic ovary syndrome (PCOS) – a review of clinical trials and cohort
    Vitoria Melo, Thomas Silva, Thaissa Silva, Juliana Freitas, Joselita Sacramento, Mirian Vazquez, Edilene Araujo
    Endocrine Regulations.2022; 56(1): 66.     CrossRef
  • The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis
    Yanan Xiao, Qifang Zhang, Xueling Liao, Ulf Elbelt, Karsten H. Weylandt
    Prostaglandins, Leukotrienes and Essential Fatty Acids.2022; 182: 102456.     CrossRef
  • Anti-inflammatory and antioxidant activity of astragalus polysaccharide in ulcerative colitis: A systematic review and meta-analysis of animal studies
    Heng-Chang Hu, Wei Zhang, Pei-Yu Xiong, Li Song, Bo Jia, Xing-Long Liu
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Eicosopenthaenoic acid: Gnawing at the perivascular adipose tissue
    Paolo Raggi, Arthur E. Stillman
    Atherosclerosis.2021; 316: 69.     CrossRef
  • The Effect of Omega-3 Fatty Acid Supplementation on Serum Adipocytokines, Lipid Profile and Biochemical Markers of Inflammation in Recreational Runners
    Aleksandra Żebrowska, Barbara Hall, Anna Stolecka-Warzecha, Arkadiusz Stanula, Ewa Sadowska-Krępa
    Nutrients.2021; 13(2): 456.     CrossRef
  • The Influence of Nutrition on Adiponectin—A Narrative Review
    Justyna Janiszewska, Joanna Ostrowska, Dorota Szostak-Węgierek
    Nutrients.2021; 13(5): 1394.     CrossRef
  • Adiponectin’s roles in lipid and glucose metabolism modulation in fish: Mechanisms and perspectives
    Renlei Ji, Xiang Xu, Giovanni M. Turchini, Kangsen Mai, Qinghui Ai
    Reviews in Aquaculture.2021; 13(4): 2305.     CrossRef
  • Omega-3 Fatty Acids and Vulnerability to Addiction: Reviewing Preclinical and Clinical Evidence
    Valerie L. Darcey, Katherine M. Serafine
    Current Pharmaceutical Design.2020; 26(20): 2385.     CrossRef
  • Therapeutic effects of different doses of prebiotic (isolated from Saccharomyces cerevisiae) in comparison to n-3 supplement on glycemic control, lipid profiles and immunological response in diabetic rats
    Janina de Sales Guilarducci, Breno Augusto Ribeiro Marcelino, Isaac Filipe Moreira Konig, Tamira Maria Orlando, Mary Suzan Varaschin, Luciano José Pereira
    Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
  • Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
    Gerwyn Morris, Basant K. Puri, Lisa Olive, Andre Carvalho, Michael Berk, Ken Walder, Lise Tuset Gustad, Michael Maes
    BMC Medicine.2020;[Epub]     CrossRef
  • Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus
    Hengchang Hu, Yuanhong Lei, Liping Yin, Xiaoqiong Luo
    Medicine.2020; 99(47): e22735.     CrossRef
  • Omega-3 polyunsaturated fatty acids in supporting pregnancy and fetal development: dosing considerations
    Olga A. Gromova, Ivan Iu. Torshin, Tatiana R. Grishina, Svetlana I. Maliavskaia
    Gynecology.2020; 22(5): 61.     CrossRef
  • A Significant Association Between Rhein and Diabetic Nephropathy in Animals: A Systematic Review and Meta-Analysis
    Heng-Chang Hu, Liu-Tao Zheng, Hai-Yan Yin, Yuan Tao, Xiao-Qiong Luo, Kai-Shan Wei, Li-Ping Yin
    Frontiers in Pharmacology.2019;[Epub]     CrossRef
  • Dietary n-3 polyunsaturated fatty acids, fish intake and healthy ageing
    Esther García-Esquinas, Rosario Ortolá, Jose Ramón Banegas, Esther Lopez-García, Fernando Rodríguez-Artalejo
    International Journal of Epidemiology.2019; 48(6): 1914.     CrossRef
  • Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives
    Hidekatsu Yanai, Hiroshi Yoshida
    International Journal of Molecular Sciences.2019; 20(5): 1190.     CrossRef
  • Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases
    Ying Liu, Vivian Vu, Gary Sweeney
    Frontiers in Endocrinology.2019;[Epub]     CrossRef
Clinical Diabetes & Therapeutics
Recent Updates on Type 1 Diabetes Mellitus Management for Clinicians
Ahmed Iqbal, Peter Novodvorsky, Simon R. Heller
Diabetes Metab J. 2018;42(1):3-18.   Published online February 23, 2018
DOI: https://doi.org/10.4093/dmj.2018.42.1.3
  • 6,754 View
  • 89 Download
  • 18 Web of Science
  • 19 Crossref
AbstractAbstract PDFPubReader   

Type 1 diabetes mellitus (T1DM) is a chronic autoimmune condition that requires life-long administration of insulin. Optimal management of T1DM entails a good knowledge and understanding of this condition both by the physician and the patient. Recent introduction of novel insulin preparations, technological advances in insulin delivery and glucose monitoring, such as continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring and improved understanding of the detrimental effects of hypoglycaemia and hyperglycaemia offer new opportunities and perspectives in T1DM management. Evidence from clinical trials suggests an important role of structured patient education. Our efforts should be aimed at improved metabolic control with concomitant reduction of hypoglycaemia. Despite recent advances, these goals are not easy to achieve and can put significant pressure on people with T1DM. The approach of physicians should therefore be maximally supportive. In this review, we provide an overview of the recent advances in T1DM management focusing on novel insulin preparations, ways of insulin administration and glucose monitoring and the role of metformin or sodium-glucose co-transporter 2 inhibitors in T1DM management. We then discuss our current understanding of the effects of hypoglycaemia on human body and strategies aimed at mitigating the risks associated with hypoglycaemia.

Citations

Citations to this article as recorded by  
  • Health-Related Quality of Life of Adolescents and Children With Type 1 Diabetes in the Jazan Region of Saudi Arabia
    Gassem A Gohal, Aqilah Majhali, Esaam Moafa, Sarah H Talebi, Bushra I Maashi, Amani Mutaen, Walaa J Alhamdan, Ibrahim M Dighriri
    Cureus.2024;[Epub]     CrossRef
  • Nose-to-brain delivery of insulin nanoparticles for diabetes management: A review
    Manoj Kumbhare, Ajaykumar Surana, Pravin Morankar
    Baghdad Journal of Biochemistry and Applied Biological Sciences.2023; 4(02): 39.     CrossRef
  • Clinical Effects of a Home Care Pilot Program for Patients with Type 1 Diabetes Mellitus: A Retrospective Cohort Study
    Sejeong Lee, KyungYi Kim, Ji Eun Kim, Yura Hyun, Minyoung Lee, Myung-Il Hahm, Sang Gyu Lee, Eun Seok Kang
    Diabetes & Metabolism Journal.2023; 47(5): 693.     CrossRef
  • Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial
    Ingrid Wijk, Susanne Amsberg, Unn-Britt Johansson, Fredrik Livheim, Eva Toft, Therese Anderbro
    BMJ Open.2023; 13(12): e072061.     CrossRef
  • Role of sirtuin-1 (SIRT1) in hypoxic injury in pancreatic β-cells
    Ye-Jee Lee, Esder Lee, Young-Hye You, Yu-Bae Ahn, Ki-Ho Song, Ji-Won Kim, Seung-Hyun Ko
    Journal of Drug Targeting.2021; 29(1): 88.     CrossRef
  • Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus
    Jong Ha Baek, Woo Je Lee, Byung-Wan Lee, Soo Kyoung Kim, Gyuri Kim, Sang-Man Jin, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2021; 45(1): 46.     CrossRef
  • The impact of chemical engineering and technological advances on managing diabetes: present and future concepts
    Sabine Szunerits, Sorin Melinte, Alexandre Barras, Quentin Pagneux, Anna Voronova, Amar Abderrahmani, Rabah Boukherroub
    Chemical Society Reviews.2021; 50(3): 2102.     CrossRef
  • Surrogate markers and predictors of endogenous insulin secretion in children and adolescents with type 1 diabetes
    Jin-Na Yuan, Jian-Wei Zhang, Wayne S. Cutfield, Guan-Ping Dong, You-Jun Jiang, Wei Wu, Ke Huang, Xiao-Chun Chen, Yan Zheng, Bi-Hong Liu, José G. B. Derraik, Jun-Fen Fu
    World Journal of Pediatrics.2021; 17(1): 99.     CrossRef
  • Nano-based drug delivery systems used as vehicles to enhance polyphenols therapeutic effect for diabetes mellitus treatment
    Sónia Rocha, Mariana Lucas, Daniela Ribeiro, M. Luísa Corvo, Eduarda Fernandes, Marisa Freitas
    Pharmacological Research.2021; 169: 105604.     CrossRef
  • Dapagliflozin: an effective adjunctive treatment in type 1 diabetes
    Ghasem Yadegarfar, Mark Livingston, Gabriela Cortes, Ramadan Alshames, Kate Leivesley, Ann Metters, Linda Horne, Tom Steele, Adrian H. Heald
    Cardiovascular Endocrinology & Metabolism.2021; 10(2): 132.     CrossRef
  • Association between reduced serum levels of magnesium and the presence of poor glycemic control and complications in type 1 diabetes mellitus: A systematic review and meta-analysis
    Ana Kelen Rodrigues, Ana Elisa Melo, Caroline Pereira Domingueti
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(2): 127.     CrossRef
  • Insulin-Producing Cell Transplantation Platform for Veterinary Practice
    Suryo Kuncorojakti, Sayamon Srisuwatanasagul, Krishaporn Kradangnga, Chenphop Sawangmake
    Frontiers in Veterinary Science.2020;[Epub]     CrossRef
  • Type 1 Diabetes Home Care Project and Educational Consultation
    Eun Chong Shin
    The Journal of Korean Diabetes.2020; 21(2): 88.     CrossRef
  • Decision-Making in Artificial Intelligence: Is It Always Correct?
    Hun-Sung Kim
    Journal of Korean Medical Science.2020;[Epub]     CrossRef
  • The FreeStyle Libre flash glucose monitoring system: how it has improved glycaemic control for people with type 1 diabetes in Eastern Cheshire, UK
    Ghasem Yadegarfar, Simon G. Anderson, Zohaib Khawaja, Gabriela Cortes, Kathryn Leivesley, Ann Metters, Linda Horne, Tom Steele, Adrian H. Heald
    Cardiovascular Endocrinology & Metabolism.2020; 9(4): 171.     CrossRef
  • Dose-dependent effects of necrostatin-1 supplementation to tissue culture media of young porcine islets
    Hien Lau, Nicole Corrales, Samuel Rodriguez, Colleen Luong, Mohammadreza Mohammadi, Veria Khosrawipour, Shiri Li, Michael Alexander, Paul de Vos, Jonathan R. T. Lakey, Zoltán Rakonczay
    PLOS ONE.2020; 15(12): e0243506.     CrossRef
  • New Insulin Pumps and Open Source Artificial Pancreas System in Korea
    Jae Hyeon Kim
    The Journal of Korean Diabetes.2020; 21(4): 197.     CrossRef
  • Perspective and general approach of diabetes in palliative care
    Díaz Rodríguez Juan Javier
    Hospice and Palliative Medicine International Journal.2018;[Epub]     CrossRef
  • The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations
    Fatemeh Delkhosh-Kasmaie, Amir Abbas Farshid, Esmaeal Tamaddonfard, Mehdi Imani
    Biomedicine & Pharmacotherapy.2018; 107: 203.     CrossRef
Obesity and Metabolic Syndrome
Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
Eun-Jung Rhee
Diabetes Metab J. 2018;42(1):19-25.   Published online January 26, 2018
DOI: https://doi.org/10.4093/dmj.2018.42.1.19
  • 3,719 View
  • 48 Download
  • 5 Web of Science
  • 7 Crossref
AbstractAbstract PDFPubReader   

The prevalence of obesity is rapidly increasing worldwide. One-thirds of world population is suffering from the deleterious effects of excessive fat and adipose tissue in their body. At the same time, the average life expectancy is becoming higher and higher every decade. Therefore, living healthy and longer is the dream for everyone. Simply being obese is not the primary cause for the consequence of obesity; rather, the depot where the fat is accumulated, is the primary key for the deleterious effects of obesity. Results from historical research suggest that visceral fat increases the risk for cardiovascular and metabolic diseases, such as diabetes, myocardial infarction and ischemic stroke, not subcutaneous fat. Therefore, body mass index (BMI), which reflects body weight relative to height might not reflect the appropriate size of metabolic burden of fat in our body. In contrast, waist circumference, which reflects abdominal obesity, would mirror the metabolic burden of fat better than BMI. Visceral fat is the marker of ectopic fat accumulation. In this review, I will introduce my researches mainly involved in uncovering the clues to the link between metabolic health and cardiovascular disease.

Citations

Citations to this article as recorded by  
  • Correlations between modest weight loss and leptin to adiponectin ratio, insulin and leptin resensitization in a small cohort of Norwegian individuals with obesity
    Victoria T. Isaksen, Maria A. Larsen, Rasmus Goll, Eyvind J. Paulssen, Jon R. Florholmen
    Endocrine and Metabolic Science.2023; 12: 100134.     CrossRef
  • Allostatic load in patients with breast cancer
    K. F. Makkonen, N. M. Agarkov, U. S. Stanoevich, A. A. Titov, M. S. Mitikhina, E. A. Moskaleva
    Siberian journal of oncology.2022; 21(4): 40.     CrossRef
  • Effect of glucocorticoids on glyceroneogenesis in adipose tissue: A systematic review
    Mariana Lima-de-Freitas Marcondes-de-Mello, Maria Cristina Serafim-Costa, Mariela Mesquita Alves-e-Silva, Natália Rodrigues Oliveira, Nicola Vasconcellos Bertolucci-Caldo, Ruan Krubniki Ferraz, Valéria Ernestânia Chaves
    Biochimie.2020; 168: 210.     CrossRef
  • Risk of type 2 diabetes according to the cumulative exposure to metabolic syndrome or obesity: A nationwide population‐based study
    You‐Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han, Hye Jin Yoo
    Journal of Diabetes Investigation.2020; 11(6): 1583.     CrossRef
  • Hospitalization for heart failure incidence according to the transition in metabolic health and obesity status: a nationwide population-based study
    You-Bin Lee, Da Hye Kim, Seon Mee Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Yong Gyu Park, Kyungdo Han, Hye Jin Yoo
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Profound Perturbation of the Metabolome in Obesity Is Associated with Health Risk
    Elizabeth T. Cirulli, Lining Guo, Christine Leon Swisher, Naisha Shah, Lei Huang, Lori A. Napier, Ewen F. Kirkness, Tim D. Spector, C. Thomas Caskey, Bernard Thorens, J. Craig Venter, Amalio Telenti
    Cell Metabolism.2019; 29(2): 488.     CrossRef
  • Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study
    Jung A Kim, Da Hye Kim, Seon Mee Kim, Yong Gyu Park, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi, Kyungdo Han, Hye Jin Yoo
    Endocrinology and Metabolism.2019; 34(4): 406.     CrossRef
Clinical Diabetes & Therapeutics
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi
Diabetes Metab J. 2017;41(6):423-429.   Published online December 19, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.6.423
  • 5,787 View
  • 71 Download
  • 5 Web of Science
  • 6 Crossref
AbstractAbstract PDFPubReader   

The glucagon-like peptide-1 receptor agonists (GLP-1RAs) were recommended as a monotherapy or combination therapy with oral hypoglycemic agents or basal insulin in the position statement of the Korean Diabetes Association 2017 for pharmacological therapy. Many randomized clinical trials and systematic reviews report that GLP-1RAs have considerable glucose-lowering effect and lead to weight reduction and low risk of hypoglycemia when used as a monotherapy or combination therapy. The cardiovascular safety of GLP-1RAs has been assessed in several randomized clinical trials and systematic reviews. The results of cardiovascular outcome trials of long-acting GLP-1RAs (liraglutide, semaglutide) demonstrated cardiovascular benefits in subjects with type 2 diabetes mellitus and a high risk of cardiovascular disease. The GLP-1RA may be a choice of therapy when weight control and avoidance of hypoglycemia are important, and patients with high risk of cardiovascular disease might also favor choosing GLP-1RA.

Citations

Citations to this article as recorded by  
  • Anti-inflammatory effect of glucagon-like Peptide-1 receptor agonist on the neurosensory retina in an acute optic nerve injury rat model
    Yeon Woong Chung, Ji Young Lee, Hyun Hee Ju, Jin A. Choi
    European Journal of Pharmacology.2022; 933: 175269.     CrossRef
  • Diabetes Risk Data Mining Method Based on Electronic Medical Record Analysis
    Yang Liu, Zhaoxiang Yu, Yunlong Yang, Zhihan Lv
    Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
  • Paradigm Shift for the Treatment of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease: Cardiologist's Perspective
    Doo Soo Jeon
    Cardiovascular Prevention and Pharmacotherapy.2020; 2(1): 11.     CrossRef
  • The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia
    Ju-Ming Lu
    Advances in Therapy.2019; 36(4): 798.     CrossRef
  • A Review of Practical Issues on the Use of Glucagon-Like Peptide-1 Receptor Agonists for the Management of Type 2 Diabetes
    Irene Romera, Ana Cebrián-Cuenca, Fernando Álvarez-Guisasola, Fernando Gomez-Peralta, Jesús Reviriego
    Diabetes Therapy.2019; 10(1): 5.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Hyun Jin Kim
    The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef
Obesity and Metabolic Syndrome
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
Eugene Han, Yong-ho Lee
Diabetes Metab J. 2017;41(6):430-437.   Published online November 17, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.6.430
  • 4,930 View
  • 86 Download
  • 50 Web of Science
  • 54 Crossref
AbstractAbstract PDFPubReader   

As the number of individuals with non-alcoholic fatty liver disease (NAFLD) has increased, the influence of NAFLD on other metabolic diseases has been highlighted. Accumulating epidemiologic evidence indicates that NAFLD not only affects the liver but also increases the risk of extra-hepatic diseases such as type 2 diabetes mellitus, metabolic syndrome, dyslipidemia, hypertension, cardiovascular or cerebrovascular diseases, and chronic kidney disease. Non-alcoholic steatohepatitis, an advanced type of NAFLD, can aggravate these inter-organ relationships and lead to poorer outcomes. NAFLD induces insulin resistance and exacerbates systemic chronic inflammation and oxidative stress, which leads to organ dysfunction in extra-hepatic tissues. Although more research is needed to identify the pathophysiological mechanisms and causal relationship between NAFLD and cardiometabolic and renal diseases, screening for heart, brain, and kidney diseases, risk assessment for diabetes, and a multidisciplinary approach for managing these patients should be highly encouraged.

Citations

Citations to this article as recorded by  
  • Inter‐relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management
    Jiten Vora, David Cherney, Mikhail N. Kosiborod, Jonas Spaak, Naresh Kanumilli, Kamlesh Khunti, Carolyn S. P. Lam, Michael Bachmann, Peter Fenici
    Diabetes, Obesity and Metabolism.2024;[Epub]     CrossRef
  • Relationship between Uric Acid to High Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Nonoverweight/Obese Patients with Type 2 Diabetes
    Yuliang Cui, Zhenzhen Qu, Wenmei Hu, Haiyan Shi, Faustino R. Perez-Lopez
    International Journal of Endocrinology.2023; 2023: 1.     CrossRef
  • Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD
    Ziyan Xie, Ting Xie, Jieying Liu, Qian Zhang, Xinhua Xiao
    International Journal of Molecular Sciences.2023; 24(3): 2142.     CrossRef
  • Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
    Eugene Han, Yong-ho Lee
    Clinical and Molecular Hepatology.2023; 29(4): 980.     CrossRef
  • Factores de riesgo para fibrosis hepática en pacientes diabéticos con enfermedad renal cronica terminal
    Ismael Yepes Barreto, Diana Romero Florez, Jorge Coronado Daza
    Revista colombiana de Gastroenterología.2023; 38(3): 278.     CrossRef
  • Circ_0004535/miR-1827/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease
    Min Li, Ai Zeng, Xinle Tang, Hui Xu, Wei Xiong, Yanying Guo
    Scientific Reports.2023;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
    Cheng-Wei Yu, Chia-Hung Chen, Yung-Chi Cheng, Wen-Che Hsieh, Tzu-Ju Hsu, Fuu-Jen Tsai, Chao-Yu Hsu
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
    Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, In Jeong Oh, Da Hyun Choi, Yu seol Lee, I. Seul Park, SeungWon Kim, Da Hyun Lee, Jae Hee Cheon, Jin‐Woo Bae, Minyoung Lee, Jin Won Cho, In Bok An, Eun Joo Nam, Sang‐In Yang, Myung‐Shik Lee, Soo Han Bae
    Hepatology.2022; 75(6): 1523.     CrossRef
  • Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
    Ji-Yeon Lee, Young-eun Kim, Kyungdo Han, Eugene Han, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
    JAMA Network Open.2022; 5(2): e220262.     CrossRef
  • State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
    Yongin Cho, Yong-ho Lee
    Endocrinology and Metabolism.2022; 37(1): 38.     CrossRef
  • Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
    Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi
    BMJ Open Gastroenterology.2022; 9(1): e000913.     CrossRef
  • A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study
    Yang Zhou, Xiangping Chai, Tuo Guo, Yuting Pu, Mengping Zeng, Aifang Zhong, Guifang Yang, Jiajia Cai
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity
    Eugene Han, Mi Kyung Kim, Seung-Soon Im, Byoung Kuk Jang, Hye Soon Kim
    Journal of Diabetes and its Complications.2022; 36(8): 108253.     CrossRef
  • Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans
    Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Se Eun Park
    Journal of Personalized Medicine.2022; 12(7): 1142.     CrossRef
  • Effects of Avocado Oil Supplementation on Insulin Sensitivity, Cognition, and Inflammatory and Oxidative Stress Markers in Different Tissues of Diet-Induced Obese Mice
    Schérolin de Oliveira Marques, Alexandre Pastoris Muller, Thais Fernandes Luciano, Natália dos Santos Tramontin, Mateus da Silva Caetano, Bruno Luis da Silva Pieri, Tatiane Lima Amorim, Marcone Augusto Leal de Oliveira, Cláudio Teodoro de Souza
    Nutrients.2022; 14(14): 2906.     CrossRef
  • Relationship Between Handgrip Strength and Laboratory Values in Adolescents With Non-Alcoholic Fatty Liver Disease
    Si Yeong Lee, Yong Whi Jeong, Hong Koh, Yunkoo Kang
    Journal of Clinical Densitometry.2022; 25(4): 490.     CrossRef
  • Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns
    Liu Lei, Wang Changfa, Wang Jiangang, Chen Zhiheng, Yuan Ting, Zhu Xiaoling, Deng Yuling, Wang Yaqin
    Scientific Reports.2022;[Epub]     CrossRef
  • Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity
    Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
    Obesity.2022; 30(12): 2440.     CrossRef
  • Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study
    Akira Mima
    Scientific Reports.2022;[Epub]     CrossRef
  • Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
    Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
    Journal of Nephrology.2021; 34(3): 649.     CrossRef
  • Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis
    Zi-Ying Zhan, Mei Wu, Yue Shang, Min Jiang, Jian Liu, Chun-Ying Qiao, Huan Ye, Yong-Ce Lin, Mei-Hua Piao, Rong-Hui Sun, Zhi-Hong Zhang, Jing-Ya Jiao, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
    Food & Function.2021; 12(1): 362.     CrossRef
  • Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
    Diabetes & Metabolism Journal.2021; 45(5): 698.     CrossRef
  • The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
    Hyun Min Kim, Yong-ho Lee
    Endocrinology and Metabolism.2021; 36(6): 1232.     CrossRef
  • A preliminary report about the detection of ventricular repolarisation in patients with non-alcoholic fatty liver disease
    Marwan S. Al-Nimer, Vian A. Esmail, Dler S. Hamid, Mohammad O. Mohammad
    Journal of Taibah University Medical Sciences.2020; 15(4): 284.     CrossRef
  • Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
    Nattavadee Pengrattanachot, Rada Cherngwelling, Krit Jaikumkao, Anchalee Pongchaidecha, Laongdao Thongnak, Myat Theingi Swe, Varanuj Chatsudthipong, Anusorn Lungkaphin
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(6): 165741.     CrossRef
  • Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
    Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
    The Open Urology & Nephrology Journal.2020; 13(1): 1.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
    Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
  • Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease
    Yong-ho Lee, Seung Up Kim
    Hepatology International.2020; 14(1): 5.     CrossRef
  • Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
    Hokyou Lee, Gyuri Kim, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Diabetes & Metabolism Journal.2020; 44(2): 267.     CrossRef
  • Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
    Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
    Journal of Clinical Medicine.2020; 9(1): 259.     CrossRef
  • Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
    Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
    Eugene Han, Yongin Cho, Kyung-won Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-wan Lee
    Medicine.2020; 99(33): e21038.     CrossRef
  • Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
    Min Zhang, Su Lin, Ming-fang Wang, Jiao-feng Huang, Shi-ying Liu, Su-mei Wu, Hao-yang Zhang, Zi-mu Wu, Wen-Yue Liu, Dong-Chu Zhang, Chuan-ming Hao, Yue-yong Zhu, Ming-Hua Zheng, Xiao-zhong Wang
    BMC Gastroenterology.2020;[Epub]     CrossRef
  • Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
    Inkuk Lee, Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
    Journal of Lipid and Atherosclerosis.2020; 9(1): 195.     CrossRef
  • Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38)
    Chan-Hee Jung
    Journal of Obesity & Metabolic Syndrome.2020; 29(2): 158.     CrossRef
  • Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview
    Niki Katsiki, Anca Pantea Stoian, Paschalis Steiropoulos, Nikolaos Papanas, Andra-Iulia Suceveanu, Dimitri P. Mikhailidis
    Metabolites.2020; 10(11): 465.     CrossRef
  • Heart Failure and Liver Disease
    Andrew Xanthopoulos, Randall C. Starling, Takeshi Kitai, Filippos Triposkiadis
    JACC: Heart Failure.2019; 7(2): 87.     CrossRef
  • Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients
    Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost
    Acta Diabetologica.2019; 56(11): 1199.     CrossRef
  • Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
    Jae-Sung Ryu, Minji Lee, Seon Ju Mun, Sin-Hyoung Hong, Ho-Joon Lee, Hyo-Suk Ahn, Kyung-Sook Chung, Gun-Hwa Kim, Myung Jin Son
    Journal of Biological Engineering.2019;[Epub]     CrossRef
  • Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment
    Niki Katsiki, Vasilios G Athyros
    Current Medical Research and Opinion.2019; 35(7): 1305.     CrossRef
  • Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
    Yong-ho Lee, Yongin Cho, Byung-Wan Lee, Cheol-Young Park, Dae Ho Lee, Bong-Soo Cha, Eun-Jung Rhee
    Diabetes & Metabolism Journal.2019; 43(1): 31.     CrossRef
  • Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease
    清莲 宋
    Advances in Clinical Medicine.2019; 09(09): 1073.     CrossRef
  • Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study
    You‐Cheol Hwang, Hong‐Yup Ahn, Cheol‐Young Park
    Obesity.2019; 27(8): 1360.     CrossRef
  • Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function
    Jin Kwon Jeong, Julie A. Horwath, Hayk Simonyan, Katherine A. Blackmore, Scott D. Butler, Colin N. Young
    Physiological Genomics.2019; 51(8): 333.     CrossRef
  • Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
    Kyung-Soo Kim, Byung-Wan Lee, Yong Jin Kim, Dae Ho Lee, Bong-Soo Cha, Cheol-Young Park
    Diabetes & Metabolism Journal.2019; 43(2): 127.     CrossRef
  • Chicken Protein Hydrolysates Have Anti-Inflammatory Effects on High-Fat Diet Induced Obesity in Mice
    Thomas Aloysius, Ana Carvajal, Rasa Slizyte, Jon Skorve, Rolf Berge, Bodil Bjørndal
    Medicines.2018; 6(1): 5.     CrossRef
  • STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia
    Emmelie Cansby, Elin Magnusson, Esther Nuñez-Durán, Manoj Amrutkar, Matteo Pedrelli, Paolo Parini, Jenny Hoffmann, Marcus Ståhlman, Brian W. Howell, Hanns-Ulrich Marschall, Jan Borén, Margit Mahlapuu
    Arteriosclerosis, Thrombosis, and Vascular Biology.2018; 38(8): 1723.     CrossRef
  • Organ-Specific Mechanisms of Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta
    Sanne L. Maas, Oliver Soehnlein, Joana R. Viola
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • Visceral adiposity index as a predictor of NAFLD: A prospective study with 4‐year follow‐up
    Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang
    Liver International.2018; 38(12): 2294.     CrossRef
  • Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age
    Alfonso M. Lechuga-Sancho, David Gallego-Andujar, Pablo Ruiz-Ocaña, Francisco M. Visiedo, Ana Saez-Benito, Mónica Schwarz, Carmen Segundo, Rosa M. Mateos, Manuel Portero-Otin
    PLOS ONE.2018; 13(1): e0191547.     CrossRef
  • Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
    Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho
    Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
  • Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure
    Jia Yao, Xiaoshuang Zhou, Hui Wang, Lili Yuan, Yu Chen, Zhongping Duan
    Annals of Nutrition and Metabolism.2018; 73(1): 2.     CrossRef
  • The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
    Dong Wang, Yuhuan Luo, Xiaoxin Wang, David Orlicky, Komuraiah Myakala, Pengyuan Yang, Moshe Levi
    International Journal of Molecular Sciences.2018; 19(1): 137.     CrossRef
  • Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
    Jing Luo, Qian Chen, Tianran Shen, Xu Wang, Wanjun Fang, Xiaocai Wu, Zenan Yuan, Gengdong Chen, Wenhua Ling, Yuming Chen
    Nutrition & Metabolism.2018;[Epub]     CrossRef
Clinical Diabetes & Therapeutics
Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
Diabetes Metab J. 2017;41(5):367-373.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.367
  • 7,414 View
  • 220 Download
  • 7 Web of Science
  • 9 Crossref
AbstractAbstract PDFPubReader   

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Citations

Citations to this article as recorded by  
  • Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
    Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Jae-Myung Yu, Hye Soon Kim, Hyun Jin Kim, Won Kim, Dong Han Kim, Hak Chul Jang
    Advances in Therapy.2024;[Epub]     CrossRef
  • Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
    Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Effects of an actual insulin injection demonstration on insulin acceptance among patients with T2DM: a pragmatic randomized controlled trial
    Atthayaporn Choomai, Apichai Wattanapisit, Orathai Tiangtam
    Romanian Journal of Internal Medicine.2021; 59(2): 151.     CrossRef
  • Favorable Glycemic Control with Once-Daily Insulin Degludec/Insulin Aspart after Changing from Basal Insulin in Adults with Type 2 Diabetes
    Han Na Jang, Ye Seul Yang, Seong Ok Lee, Tae Jung Oh, Bo Kyung Koo, Hye Seung Jung
    Endocrinology and Metabolism.2019; 34(4): 382.     CrossRef
  • Capacity and confidence building for general practitioners on optimum insulin use
    Sanjay Kalra, Prasun Deb, KalyanK Gangopadhyay, Sunil Gupta, Abhay Ahluwalia
    Journal of Family Medicine and Primary Care.2019; 8(10): 3096.     CrossRef
  • Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
    Eun Chong Shin
    The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
  • Summary of Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee
    The Journal of Korean Diabetes.2018; 19(1): 31.     CrossRef
  • New anti-diabetic agents
    Doo-Man Kim
    Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef
Clinical Diabetes & Therapeutics
Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
Min Kyong Moon, Kyu-Yeon Hur, Seung-Hyun Ko, Seok-O Park, Byung-Wan Lee, Jin Hwa Kim, Sang Youl Rhee, Hyun Jin Kim, Kyung Mook Choi, Nan-Hee Kim
Diabetes Metab J. 2017;41(5):357-366.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.357
  • 7,604 View
  • 150 Download
  • 17 Web of Science
  • 15 Crossref
AbstractAbstract PDFPubReader   

The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic agents (OHAs), general recommendations were not changed from those of the 2015 KDA guidelines. The Committee on Clinical Practice Guidelines of the KDA has extensively reviewed and discussed the results of meta-analyses and systematic reviews of effectiveness and safety of OHAs and many clinical trials on Korean patients with T2DM for the update of guidelines. All OHAs were effective when added to metformin or metformin and sulfonylurea, although the effects of each agent on body weight and hypoglycemia were different. Therefore, selection of a second agent as a metformin add-on therapy or third agent as a metformin and sulfonylurea add-on therapy should be based on the patient's clinical characteristics and the efficacy, side effects, mechanism of action, risk of hypoglycemia, effect on body weight, patient preference, and combined comorbidity. In this review, we address the results of meta-analyses and systematic reviews, comparing the effectiveness and safety among OHAs. It will help to choose the appropriate drug for an individual patient with T2DM.

Citations

Citations to this article as recorded by  
  • Unveiling the potential of prodrug and drug-conjugate strategies in treatment of diabetes mellitus and its complications
    Neha V. Bhilare, Rushikesh Shedge, Prashant M. Tambe, Ajinkya More
    Medicinal Chemistry Research.2024; 33(3): 337.     CrossRef
  • Simultaneous Estimation of Repaglinide and Voglibose in Newly Approved Fixed-Dose Combination by using UFLC: Application to ICH Q14 Concept and Comparative Method Greenness Assessment
    S.S. Panda, P.C. Rauta, V.S. Pulusu, S. Sahu, B.B. Dash
    Asian Journal of Chemistry.2023; 35(4): 887.     CrossRef
  • Time to reposition sulfonylureas in type 2 diabetes management in Indian context: A pragmatic practical approach
    Ashok Kumar Das, Banshi Saboo, Rajeev Chawla, S. R. Aravind, Rajesh Rajput, Awadhesh K. Singh, J. J. Mukherjee, Ashok Jhingan, Parag Shah, Vaishali Deshmukh, Shailaja Kale, Shalini Jaggi, G. R. Sridhar, Rajnish Dhediya, Kumar Gaurav
    International Journal of Diabetes in Developing Countries.2023; 43(6): 856.     CrossRef
  • The Gut Microbiome, Metformin, and Aging
    Sri Nitya Reddy Induri, Payalben Kansara, Scott C. Thomas, Fangxi Xu, Deepak Saxena, Xin Li
    Annual Review of Pharmacology and Toxicology.2022; 62(1): 85.     CrossRef
  • Role of resveratrol supplementation in regulation of glucose hemostasis, inflammation and oxidative stress in patients with diabetes mellitus type 2: A randomized, placebo-controlled trial
    Wajiha Mahjabeen, Dilshad Ahmed Khan, Shakil Ahmed Mirza
    Complementary Therapies in Medicine.2022; 66: 102819.     CrossRef
  • Letrozole: Pharmacology, toxicity and potential therapeutic effects
    Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Dhanushya Nagarajan, Vibhaa K K, Anagha V, Joshua Paul P, Tharani Priya T, Rituraj Chakraborty, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Abilash Valsala Gopalakrishnan
    Life Sciences.2022; 310: 121074.     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Treatment intensification in type 2 diabetes management after the failure of two oral hypoglycemic agents: A non‐interventional comparative study
    Sirajudeen Shaik Alavudeen, Sultan M. Alshahrani, Easwaran Vigneshwaran, Noohu Abdulla Khan, Javid I. Mir, Abubakr T. M. Hussein
    International Journal of Clinical Practice.2021;[Epub]     CrossRef
  • Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus
    Antonios Kousaxidis, Anthi Petrou, Vasiliki Lavrentaki, Maria Fesatidou, Ioannis Nicolaou, Athina Geronikaki
    European Journal of Medicinal Chemistry.2020; 207: 112742.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • A Survey of the Structures of US FDA Approved Combination Drugs
    Pradipta Das, Michael D. Delost, Munaum H. Qureshi, David T. Smith, Jon T. Njardarson
    Journal of Medicinal Chemistry.2019; 62(9): 4265.     CrossRef
  • Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets
    Marianne A. Mahrouse, Nesrine T. Lamie
    Microchemical Journal.2019; 147: 691.     CrossRef
  • The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea
    Da Young Lee, Ji Hee Yu, Sanghyun Park, Kyungdo Han, Nam Hoon Kim, Hye Jin Yoo, Kyung Mook Choi, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo
    Scientific Reports.2018;[Epub]     CrossRef
  • Effect of Lifestyle Modification and Oral Anti-Diabetic Drugs on Metabolic Parameters in Recently Diagnosed Patientswith Uncomplicated Type 2 Diabetes Mellitus in Eastern India
    Nikhilesh Pradhan, Sidhartha Das, Anoj Kumar Baliarsinha, Ashirbad Parhi, Bijan Patnaik, Pramod Kumar Rout
    Journal of Diabetes Mellitus.2018; 08(02): 9.     CrossRef
  • Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program
    Ja Young Jeon, Soo Jin Lee, Sieun Lee, Soo Jin Kim, Seung Jin Han, Hae Jin Kim, Dae Jung Kim, Young Seol Kim, Jeong Taek Woo, Kyu Jeung Ahn, Moonsuk Nam, Sei Hyun Baik, Yongsoo Park, Kwan‐Woo Lee
    Journal of Diabetes Investigation.2018; 9(5): 1144.     CrossRef
Obesity and Metabolic Syndrome
Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism
Muthu Periasamy, Jose Luis Herrera, Felipe C. G. Reis
Diabetes Metab J. 2017;41(5):327-336.   Published online October 24, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.327
  • 8,830 View
  • 207 Download
  • 110 Web of Science
  • 115 Crossref
AbstractAbstract PDFPubReader   

Obesity and diabetes has become a major epidemic across the globe. Controlling obesity has been a challenge since this would require either increased physical activity or reduced caloric intake; both are difficult to enforce. There has been renewed interest in exploiting pathways such as uncoupling protein 1 (UCP1)-mediated uncoupling in brown adipose tissue (BAT) and white adipose tissue to increase energy expenditure to control weight gain. However, relying on UCP1-based thermogenesis alone may not be sufficient to control obesity in humans. On the other hand, skeletal muscle is the largest organ and a major contributor to basal metabolic rate and increasing energy expenditure in muscle through nonshivering thermogenic mechanisms, which can substantially affect whole body metabolism and weight gain. In this review we will describe the role of Sarcolipin-mediated uncoupling of Sarcoplasmic Reticulum Calcium ATPase (SERCA) as a potential mechanism for increased energy expenditure both during cold and diet-induced thermogenesis.

Citations

Citations to this article as recorded by  
  • Nutrition as the foundation for successful aging: a focus on dietary protein and omega-3 polyunsaturated fatty acids
    Aubree L Hawley, Jamie I Baum
    Nutrition Reviews.2024; 82(3): 389.     CrossRef
  • Seasonal adaptation of Mangalica pigs in terms of muscle morphology and metabolism
    Sangwoo Kim, Chisato Nakayama, Daisuke Kondoh, Tatsuki Okazaki, Erina Yoneda, Kisaki Tomita, Motoki Sasaki, Yuki Muranishi
    Anatomia, Histologia, Embryologia.2024;[Epub]     CrossRef
  • In vivo heat production dynamics during a contraction-relaxation cycle in rat single skeletal muscle fibers
    Ayaka Tabuchi, Yoshinori Tanaka, Hiroshi Horikawa, Takuto Tazawa, David C. Poole, Yutaka Kano
    Journal of Thermal Biology.2024; 119: 103760.     CrossRef
  • Echinacoside stimulates myogenesis and ATP-dependent thermogenesis in the skeletal muscle via the activation of D1-like dopaminergic receptors
    Kiros Haddish, Jong Won Yun
    Archives of Biochemistry and Biophysics.2024; 752: 109886.     CrossRef
  • Ectodysplasin A2 receptor signaling in skeletal muscle pathophysiology
    Sevgi Döndü Özen, Serkan Kir
    Trends in Molecular Medicine.2024;[Epub]     CrossRef
  • Chronic melatonin treatment improves obesity by inducing uncoupling of skeletal muscle SERCA-SLN mediated by CaMKII/AMPK/PGC1α pathway and mitochondrial biogenesis in female and male Zücker diabetic fatty rats
    D. Salagre, M. Navarro-Alarcón, M. Villalón-Mir, B. Alcázar-Navarrete, G. Gómez-Moreno, F. Tamimi, A. Agil
    Biomedicine & Pharmacotherapy.2024; 172: 116314.     CrossRef
  • The effect of high fat diet and endurance training on newly discovery of nonshivering-thermogenic factors under thermoneutrality in mice
    S. Daneshyar, A. Ghasemnian, Z. Mirakhori, S.J. Daneshyar
    Science & Sports.2023; 38(3): 293.     CrossRef
  • Redox‐metabolic reprogramming of skin in mice lacking functional Nrf2 under basal conditions and cold acclimation
    Tamara Zakic, Sara Stojanovic, Aleksandra Jankovic, Aleksandra Korac, Vanja Pekovic‐Vaughan, Bato Korac
    BioFactors.2023; 49(3): 600.     CrossRef
  • Rats lackingUcp1present a novel translational tool for the investigation of thermogenic adaptation during cold challenge
    Jaycob D. Warfel, Carrie M. Elks, David S. Bayless, Bolormaa Vandanmagsar, Allison C. Stone, Samuel E. Velasquez, Paola Olivares‐Nazar, Robert C. Noland, Sujoy Ghosh, Jingying Zhang, Randall L. Mynatt
    Acta Physiologica.2023;[Epub]     CrossRef
  • SENP2 knockdown in human adipocytes reduces glucose metabolism and lipid accumulation, while increases lipid oxidation
    Solveig A. Krapf, Jenny Lund, Hege G. Bakke, Tuula A. Nyman, Stefano Bartesaghi, Xiao-Rong Peng, Arild C. Rustan, G. Hege Thoresen, Eili T. Kase
    Metabolism Open.2023; 18: 100234.     CrossRef
  • Physiological and molecular mechanisms of cold-induced improvements in glucose homeostasis in humans beyond brown adipose tissue
    Sten van Beek, Dzhansel Hashim, Tore Bengtsson, Joris Hoeks
    International Journal of Obesity.2023; 47(5): 338.     CrossRef
  • Distinct Transcriptional Responses of Skeletal Muscle to Short-Term Cold Exposure in Tibetan Pigs and Bama Pigs
    Chunhuai Yang, Chunwei Cao, Jiali Liu, Ying Zhao, Jianfei Pan, Cong Tao, Yanfang Wang
    International Journal of Molecular Sciences.2023; 24(8): 7431.     CrossRef
  • Distinct and shared endothermic strategies in the heat producing tissues of tuna and other teleosts
    Baosheng Wu, Xueli Gao, Mingling Hu, Jing Hu, Tianming Lan, Tingfeng Xue, Wenjie Xu, Chenglong Zhu, Yuan Yuan, Jiangmin Zheng, Tao Qin, Peidong Xin, Ye Li, Li Gong, Chenguang Feng, Shunping He, Huan Liu, Haimeng Li, Qing Wang, Zhenhua Ma, Qiang Qiu, Kun W
    Science China Life Sciences.2023; 66(11): 2629.     CrossRef
  • Macrophage Involvement in Aging-Associated Skeletal Muscle Regeneration
    Chang-Yi Cui, Luigi Ferrucci, Myriam Gorospe
    Cells.2023; 12(9): 1214.     CrossRef
  • Anti-nucleolin aptamer, iSN04, inhibits the inflammatory responses in C2C12 myoblasts by modulating the β-catenin/NF-κB signaling pathway
    Machi Yamamoto, Mana Miyoshi, Kamino Morioka, Takakazu Mitani, Tomohide Takaya
    Biochemical and Biophysical Research Communications.2023; 664: 1.     CrossRef
  • Building Cetacean Locomotor Muscles throughout Ontogeny to Support High-Performance Swimming into Adulthood
    S R Noren
    Integrative And Comparative Biology.2023; 63(3): 785.     CrossRef
  • Filbertone, (2E)-5-methyl-2-hepten-4-one, regulates thermogenesis and lipid metabolism in skeletal muscle of a high-fat diet fed mice
    Hyemee Kim, Byungyong Ahn
    Applied Biological Chemistry.2023;[Epub]     CrossRef
  • Silencing of dopamine receptor D5 inhibits the browning of 3T3-L1 adipocytes and ATP-consuming futile cycles in C2C12 muscle cells
    Kiros Haddish, Jong Won Yun
    Archives of Physiology and Biochemistry.2023; : 1.     CrossRef
  • Dynamic of irisin secretion change after moderate-intensity chronic physical exercise on obese female
    Desiana Merawati, Sugiharto, Hendra Susanto, Ahmad Taufiq, Adi Pranoto, Dessy Amelia, Purwo Sri Rejeki
    Journal of Basic and Clinical Physiology and Pharmacology.2023; 34(4): 539.     CrossRef
  • Polyamines and Physical Activity in Musculoskeletal Diseases: A Potential Therapeutic Challenge
    Letizia Galasso, Annalisa Cappella, Antonino Mulè, Lucia Castelli, Andrea Ciorciari, Alessandra Stacchiotti, Angela Montaruli
    International Journal of Molecular Sciences.2023; 24(12): 9798.     CrossRef
  • Phosphate toxicity and SERCA2a dysfunction in sudden cardiac arrest
    Ronald B. Brown
    The FASEB Journal.2023;[Epub]     CrossRef
  • Hepatic protein kinase Cbeta deficiency mitigates late-onset obesity
    Yaoling Shu, Nikhil Gumma, Faizule Hassan, Daniel A. Branch, Lisa A. Baer, Michael C. Ostrowski, Kristin I. Stanford, Kedryn K. Baskin, Kamal D. Mehta
    Journal of Biological Chemistry.2023; 299(8): 104917.     CrossRef
  • Functional expression of the thermally activated transient receptor potential channels TRPA1 and TRPM8 in human myotubes
    Christine Skagen, Nils Gunnar Løvsletten, Lucia Asoawe, Zeineb Al-Karbawi, Arild C. Rustan, G. Hege Thoresen, Fred Haugen
    Journal of Thermal Biology.2023; 116: 103623.     CrossRef
  • Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management
    Ummul Fathima Shaik Mohamed Sayed, Said Moshawih, Hui Poh Goh, Nurolaini Kifli, Gaurav Gupta, Sachin Kumar Singh, Dinesh Kumar Chellappan, Kamal Dua, Andi Hermansyah, Hooi Leng Ser, Long Chiau Ming, Bey Hing Goh
    Frontiers in Pharmacology.2023;[Epub]     CrossRef
  • Recent advancements in pharmacological strategies to modulate energy balance for combating obesity
    Benudhara Pati, Satyabrata Sendh, Bijayashree Sahu, Sunil Pani, Nivedita Jena, Naresh Chandra Bal
    RSC Medicinal Chemistry.2023; 14(8): 1429.     CrossRef
  • CCE and EODF as two distinct non-shivering thermogenesis models inducing weight loss
    Tianyi Xu, Juan Wang, Hongwei Shi, Xiaofang Wei, Huiling Zhang, Yunyan Ji, Shiting Lu, Yi Yan, Xiuju Yu, Xiaomao Luo, Haidong Wang
    Pflügers Archiv - European Journal of Physiology.2023; 475(8): 961.     CrossRef
  • Birth and the Pathway to Adulthood: Integration across Development, Environment, and Evolution
    Christopher J Mayerl, Terry R Dial, Mark C Mainwaring, Ashley M Heers, Rebecca Z German
    Integrative And Comparative Biology.2023; 63(3): 548.     CrossRef
  • Adipose Tissue and Metabolic Health
    Sung-Min An, Seung-Hee Cho, John C. Yoon
    Diabetes & Metabolism Journal.2023; 47(5): 595.     CrossRef
  • The RANK-RANK-L-OPG pathway: trait d’union between bone and muscle
    Giovanni Iolascon, Sara Liguori, Marco Paoletta, Federica Tomaino, Antimo Moretti
    International Journal of Bone Fragility.2023; 3(2): 56.     CrossRef
  • Warm Cells, Hot Mitochondria: Achievements and Problems of Ultralocal Thermometry
    Alexey G. Kruglov, Alexey M. Romshin, Anna B. Nikiforova, Arina Plotnikova, Igor I. Vlasov
    International Journal of Molecular Sciences.2023; 24(23): 16955.     CrossRef
  • Plant extracts in prevention of obesity
    Han-Ning Wang, Jin-Zhu Xiang, Zhi Qi, Min Du
    Critical Reviews in Food Science and Nutrition.2022; 62(8): 2221.     CrossRef
  • Transcription factor EB enhances autophagy and ameliorates palmitate‐induced insulin resistance at least partly via upregulating AMPK activity in skeletal muscle cells
    Ping Wang, Chun Guang Li, Xian Zhou, Shuzhe Ding
    Clinical and Experimental Pharmacology and Physiology.2022; 49(2): 302.     CrossRef
  • ATP-consuming futile cycles as energy dissipating mechanisms to counteract obesity
    Alexandra J. Brownstein, Michaela Veliova, Rebeca Acin-Perez, Marc Liesa, Orian S. Shirihai
    Reviews in Endocrine and Metabolic Disorders.2022; 23(1): 121.     CrossRef
  • Skeletal muscle plasticity and thermogenesis: Insights from sea otters
    Traver Wright, Melinda Sheffield-Moore
    Temperature.2022; 9(2): 119.     CrossRef
  • Augmented CCL5/CCR5 signaling in brown adipose tissue inhibits adaptive thermogenesis and worsens insulin resistance in obesity
    Pei-Chi Chan, Li-Man Hung, Jiung-Pang Huang, Yuan-Ji Day, Chao-Lan Yu, Feng-Chih Kuo, Chieh-Hua Lu, Yu-Feng Tian, Po-Shiuan Hsieh
    Clinical Science.2022; 136(1): 121.     CrossRef
  • Altered muscle mitochondrial, inflammatory and trophic markers, and reduced exercise training adaptations in type 1 diabetes
    Dean Minnock, Giosuè Annibalini, Giacomo Valli, Roberta Saltarelli, Mauricio Krause, Elena Barbieri, Giuseppe De Vito
    The Journal of Physiology.2022; 600(6): 1405.     CrossRef
  • Maternal exercise intergenerationally drives muscle-based thermogenesis via activation of apelin-AMPK signaling
    Jun Seok Son, Song Ah Chae, Liang Zhao, Hongyang Wang, Jeanene M. de Avila, Mei-Jun Zhu, Zhihua Jiang, Min Du
    eBioMedicine.2022; 76: 103842.     CrossRef
  • Ca 2+ leak through ryanodine receptor 1 regulates thermogenesis in resting skeletal muscle
    Aldo Meizoso-Huesca, Luke Pearce, Christopher J. Barclay, Bradley S. Launikonis
    Proceedings of the National Academy of Sciences.2022;[Epub]     CrossRef
  • Deep transcranial magnetic stimulation in combination with skin thermography in obesity: a window on sympathetic nervous system
    Anna Ferrulli, Sara Gandini, Giulio Cammarata, Veronica Redaelli, Stefano Massarini, Concetta Macrì, Ileana Terruzzi, Daniele Cannavaro, Fabio Luzi, Livio Luzi
    Acta Diabetologica.2022; 59(5): 729.     CrossRef
  • Knockdown of sarcolipin (SLN) impairs substrate utilization in human skeletal muscle cells
    Abel M. Mengeste, Parmeshwar Katare, Andrea Dalmao Fernandez, Jenny Lund, Hege G. Bakke, David Baker, Stefano Bartesaghi, Xiao-Rong Peng, Arild C. Rustan, G. Hege Thoresen, Eili Tranheim Kase
    Molecular Biology Reports.2022; 49(7): 6005.     CrossRef
  • The Role of Thyroid Hormones on Skeletal Muscle Thermogenesis
    Nadia Sawicka-Gutaj, Abikasinee Erampamoorthy, Ariadna Zybek-Kocik, Angelos Kyriacou, Małgorzata Zgorzalewicz-Stachowiak, Agata Czarnywojtek, Marek Ruchała
    Metabolites.2022; 12(4): 336.     CrossRef
  • SS‐31 does not prevent or reduce muscle atrophy 7 days after a 65 kdyne contusion spinal cord injury in young male mice
    Zachary A. Graham, Jennifer J. DeBerry, Christopher P. Cardozo, Marcas M. Bamman
    Physiological Reports.2022;[Epub]     CrossRef
  • Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C (MOTS-c)
    Tae Kwan Yoon, Chan Hee Lee, Obin Kwon, Min-Seon Kim
    Diabetes & Metabolism Journal.2022; 46(3): 402.     CrossRef
  • Insight Into the Metabolic Adaptations of Electrically Pulse-Stimulated Human Myotubes Using Global Analysis of the Transcriptome and Proteome
    Abel M. Mengeste, Nataša Nikolić, Andrea Dalmao Fernandez, Yuan Z. Feng, Tuula A. Nyman, Sander Kersten, Fred Haugen, Eili Tranheim Kase, Vigdis Aas, Arild C. Rustan, G. Hege Thoresen
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • The Role of Thermogenic Fat Tissue in Energy Consumption
    Masato Horino, Kenji Ikeda, Tetsuya Yamada
    Current Issues in Molecular Biology.2022; 44(7): 3166.     CrossRef
  • Investigation of obesogenic effects of hexachlorobenzene, DDT and DDE in male rats
    Zeyad Ayad Fadhil Al-Obaidi, Cihan Süleyman Erdogan, Engin Sümer, Hüseyin Bugra Özgün, Burcu Gemici, Süleyman Sandal, Bayram Yilmaz
    General and Comparative Endocrinology.2022; 327: 114098.     CrossRef
  • Avian adjustments to cold and non‐shivering thermogenesis: whats, wheres and hows
    Punyadhara Pani, Naresh C. Bal
    Biological Reviews.2022; 97(6): 2106.     CrossRef
  • Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022
    Harold Edward Bays, Angela Golden, Justin Tondt
    Obesity Pillars.2022; 3: 100034.     CrossRef
  • Myogenetic Oligodeoxynucleotide Restores Differentiation and Reverses Inflammation of Myoblasts Aggravated by Cancer-Conditioned Medium
    Yuma Nihashi, Machi Yamamoto, Takeshi Shimosato, Tomohide Takaya
    Muscles.2022; 1(2): 111.     CrossRef
  • Altered skeletal muscle sarco-endoplasmic reticulum Ca2+-ATPase calcium transport efficiency after a thermogenic stimulus
    Lydia A. Heemstra, Lauren G. Koch, Steven L. Britton, Colleen M. Novak
    American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2022; 323(5): R628.     CrossRef
  • Animal Welfare Compromises Associated with Causes of Death in Neonatal Piglets
    Kirsty L. Chidgey, Nutnapong Udomteerasuwat, Patrick C. H. Morel, Fernanda Castillo-Alcala
    Animals.2022; 12(21): 2933.     CrossRef
  • Brown to White Fat Transition Overlap With Skeletal Muscle During Development of Larger Mammals: Is it a Coincidence?
    Sunil Pani, Suchanda Dey, Benudhara Pati, Unmod Senapati, Naresh C Bal
    Journal of the Endocrine Society.2022;[Epub]     CrossRef
  • Anti‐adiposity and lipid‐lowering effects of schisandrol A in diet‐induced obese mice
    Sang Ryong Kim, Hyo Jin Park, Un Ju Jung
    Journal of Food Biochemistry.2022;[Epub]     CrossRef
  • Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
    Haruki Wakai, Natsumi Abe, Touno Tokuda, Rika Yamanaka, Satoshi Ebihara, Kensuke Izumaru, Daisuke Ishii, Toru Hyodo, Kazunari Yoshida
    BMC Infectious Diseases.2022;[Epub]     CrossRef
  • Organotypic cultures as aging associated disease models
    Martina M. Sanchez, Isabella A. Bagdasarian, William Darch, Joshua T. Morgan
    Aging.2022; 14(22): 9338.     CrossRef
  • Divergent remodeling of the skeletal muscle metabolome over 24 h between young, healthy men and older, metabolically compromised men
    Jan-Frieder Harmsen, Michel van Weeghel, Rex Parsons, Georges E. Janssens, Jakob Wefers, Dirk van Moorsel, Jan Hansen, Joris Hoeks, Matthijs K.C. Hesselink, Riekelt H. Houtkooper, Patrick Schrauwen
    Cell Reports.2022; 41(11): 111786.     CrossRef
  • Structural functionality of skeletal muscle mitochondria and its correlation with metabolic diseases
    Gourabamani Swalsingh, Punyadhara Pani, Naresh C. Bal
    Clinical Science.2022; 136(24): 1851.     CrossRef
  • Trans-anethole Induces Thermogenesis via Activating SERCA/SLN Axis in C2C12 Muscle Cells
    Sulagna Mukherjee, Minji Choi, Jong Won Yun
    Biotechnology and Bioprocess Engineering.2022; 27(6): 938.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Nutmeg extract potentially alters characteristics of white adipose tissue in rats
    Ronny Lesmana, Melisa Siannoto, Gaga I. Nugraha, Hanna Goenawan, Astrid K. Feinisa, Yuni S. Pratiwi, Fifi Veronica, Vita M. Tarawan, Susianti Susianti, Unang Supratman
    Veterinary Medicine and Science.2021; 7(2): 512.     CrossRef
  • Contribution of thermogenic mechanisms by male and female mice lacking pituitary adenylate cyclase-activating polypeptide in response to cold acclimation
    Ekaterina Filatov, Landon I. Short, Maeghan A. M. Forster, Simon S. Harris, Erik N. Schien, Malcolm C. Hughes, Daemon L. Cline, Colin J. Appleby, Sarah L. Gray
    American Journal of Physiology-Endocrinology and Metabolism.2021; 320(3): E475.     CrossRef
  • Skeletal muscle non-shivering thermogenesis as an attractive strategy to combat obesity
    Hanbing Li, Can Wang, Linghuan Li, Lingqiao Li
    Life Sciences.2021; 269: 119024.     CrossRef
  • Restriction of an intron size en route to endothermy
    Jana Královičová, Ivana Borovská, Reuben Pengelly, Eunice Lee, Pavel Abaffy, Radek Šindelka, Frank Grutzner, Igor Vořechovský
    Nucleic Acids Research.2021; 49(5): 2460.     CrossRef
  • Skeletal muscle specific mitochondrial dysfunction and altered energy metabolism in a murine model (oim/oim) of severe osteogenesis imperfecta
    Victoria L. Gremminger, Emily N. Harrelson, Tara K. Crawford, Adrienne Ohler, Laura C. Schulz, R. Scott Rector, Charlotte L. Phillips
    Molecular Genetics and Metabolism.2021; 132(4): 244.     CrossRef
  • Body Protein Sparing in Hibernators: A Source for Biomedical Innovation
    Fabrice Bertile, Caroline Habold, Yvon Le Maho, Sylvain Giroud
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • The Genomes of Two Billfishes Provide Insights into the Evolution of Endothermy in Teleosts
    Baosheng Wu, Chenguang Feng, Chenglong Zhu, Wenjie Xu, Yuan Yuan, Mingliang Hu, Ke Yuan, Yongxin Li, Yandong Ren, Yang Zhou, Haifeng Jiang, Qiang Qiu, Wen Wang, Shunping He, Kun Wang, Guang Yang
    Molecular Biology and Evolution.2021; 38(6): 2413.     CrossRef
  • Is Upregulation of Sarcolipin Beneficial or Detrimental to Muscle Function?
    Naresh C. Bal, Subash C. Gupta, Meghna Pant, Danesh H. Sopariwala, Geoffrey Gonzalez-Escobedo, Joanne Turner, John S. Gunn, Christopher R. Pierson, Scott Q. Harper, Jill A. Rafael-Fortney, Muthu Periasamy
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Real‐Time Assessment of Mitochondrial Toxicity in HepG2 Cells Using the Seahorse Extracellular Flux Analyzer
    Jether Amos Espinosa, Grace Pohan, Michelle R. Arkin, Sarine Markossian
    Current Protocols.2021;[Epub]     CrossRef
  • Effects of Ecklonia stolonifera extract on the obesity and skeletal muscle regeneration in high-fat diet-fed mice
    Heegu Jin, Hyun-Ji Oh, Junghee Kim, Kang-Pyo Lee, Xionggao Han, Ok-Hwan Lee, Boo-Yong Lee
    Journal of Functional Foods.2021; 82: 104511.     CrossRef
  • The Effect of Dietary Intake and Nutritional Status on Anthropometric Development and Systemic Inflammation: An Observational Study
    Roxana Maria Martin-Hadmaș, Ștefan Adrian Martin, Adela Romonți, Cristina Oana Mărginean
    International Journal of Environmental Research and Public Health.2021; 18(11): 5635.     CrossRef
  • Thermographic imaging of mouse across circadian time reveals body surface temperature elevation associated with non-locomotor body movements
    Hiroyuki Shimatani, Yuichi Inoue, Yota Maekawa, Takahito Miyake, Yoshiaki Yamaguchi, Masao Doi, Nicolas Cermakian
    PLOS ONE.2021; 16(5): e0252447.     CrossRef
  • Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
    Andreia Gomes, Pedro Coelho, Raquel Soares, Raquel Costa
    Cell and Tissue Research.2021; 385(3): 497.     CrossRef
  • Central vs. Peripheral Action of Thyroid Hormone in Adaptive Thermogenesis: A Burning Topic
    Yanis Zekri, Frédéric Flamant, Karine Gauthier
    Cells.2021; 10(6): 1327.     CrossRef
  • Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus
    Shunichi Nakamura, Shinichi Yonekura, Takeshi Shimosato, Tomohide Takaya
    Frontiers in Physiology.2021;[Epub]     CrossRef
  • Lipophorin receptor 1 (LpR1) in Drosophila muscle influences life span by regulating mitochondrial aging
    Ae-kyeong Kim, Dae-Woo Kwon, Eunbyul Yeom, Kwang-Pyo Lee, Ki-Sun Kwon, Kweon Yu, Kyu-Sun Lee
    Biochemical and Biophysical Research Communications.2021; 568: 95.     CrossRef
  • Skeletal muscle thermogenesis enables aquatic life in the smallest marine mammal
    Traver Wright, Randall W. Davis, Heidi C. Pearson, Michael Murray, Melinda Sheffield-Moore
    Science.2021; 373(6551): 223.     CrossRef
  • Myoglobin, expressed in brown adipose tissue of mice, regulates the content and activity of mitochondria and lipid droplets
    Mostafa A. Aboouf, Julia Armbruster, Markus Thiersch, Max Gassmann, Axel Gödecke, Erich Gnaiger, Glen Kristiansen, Anne Bicker, Thomas Hankeln, Hao Zhu, Thomas A. Gorr
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2021; 1866(12): 159026.     CrossRef
  • Skeletal muscle energy metabolism in obesity
    Abel M. Mengeste, Arild C. Rustan, Jenny Lund
    Obesity.2021; 29(10): 1582.     CrossRef
  • Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration
    Mei Wan, Elise F. Gray-Gaillard, Jennifer H. Elisseeff
    Bone Research.2021;[Epub]     CrossRef
  • The small molecule SERCA activator CDN1163 increases energy metabolism in human skeletal muscle cells
    Abel M. Mengeste, Jenny Lund, Parmeshwar Katare, Roya Ghobadi, Hege G. Bakke, Per Kristian Lunde, Lars Eide, Gavin O’ Mahony, Sven Göpel, Xiao-Rong Peng, Eili Tranheim Kase, G. Hege Thoresen, Arild C. Rustan
    Current Research in Pharmacology and Drug Discovery.2021; 2: 100060.     CrossRef
  • Antioxidant Properties and Cytoprotective Effect of Pistacia lentiscus L. Seed Oil against 7β-Hydroxycholesterol-Induced Toxicity in C2C12 Myoblasts: Reduction in Oxidative Stress, Mitochondrial and Peroxisomal Dysfunctions and Attenuation of Cell Death
    Imen Ghzaiel, Amira Zarrouk, Thomas Nury, Michela Libergoli, Francesca Florio, Souha Hammouda, Franck Ménétrier, Laure Avoscan, Aline Yammine, Mohammad Samadi, Norbert Latruffe, Stefano Biressi, Débora Levy, Sérgio Paulo Bydlowski, Sonia Hammami, Anne Vej
    Antioxidants.2021; 10(11): 1772.     CrossRef
  • Role of Peroxisome Proliferator-Activated Receptors (PPARs) in Energy Homeostasis of Dairy Animals: Exploiting Their Modulation through Nutrigenomic Interventions
    Faiz-ul Hassan, Asif Nadeem, Zhipeng Li, Maryam Javed, Qingyou Liu, Jahanzaib Azhar, Muhammad Saif-ur Rehman, Kuiqing Cui, Saif ur Rehman
    International Journal of Molecular Sciences.2021; 22(22): 12463.     CrossRef
  • Differential Effects of 25-Hydroxyvitamin D3 versus 1α 25-Dihydroxyvitamin D3 on Adipose Tissue Browning in CKD-Associated Cachexia
    Robert H. Mak, Uwe Querfeld, Alex Gonzalez, Sujana Gunta, Wai W. Cheung
    Cells.2021; 10(12): 3382.     CrossRef
  • Effects of Starvation on Antioxidant-Related Signaling Molecules, Oxidative Stress, and Autophagy in Juvenile Chinese Perch Skeletal Muscle
    Ping Wu, Aimin Wang, Jia Cheng, Lin Chen, Yaxiong Pan, Honghui Li, Qi Zhang, Jiaqi Zhang, Wuying Chu, Jianshe Zhang
    Marine Biotechnology.2020; 22(1): 81.     CrossRef
  • Thermogenic adipocytes: lineage, function and therapeutic potential
    Alice E. Pollard, David Carling
    Biochemical Journal.2020; 477(11): 2071.     CrossRef
  • Hypoglycaemic effect of catalpol in a mouse model of high-fat diet-induced prediabetes
    Dengqiu Xu, Xiaofei Huang, Hozeifa M. Hassan, Lu Wang, Sijia Li, Zhenzhou Jiang, Luyong Zhang, Tao Wang
    Applied Physiology, Nutrition, and Metabolism.2020; 45(10): 1127.     CrossRef
  • The evolution of mechanisms involved in vertebrate endothermy
    Lucas J. Legendre, Donald Davesne
    Philosophical Transactions of the Royal Society B: Biological Sciences.2020; 375(1793): 20190136.     CrossRef
  • Uncoupling of sarcoendoplasmic reticulum calcium ATPase pump activity by sarcolipin as the basis for muscle non-shivering thermogenesis
    Naresh C. Bal, Muthu Periasamy
    Philosophical Transactions of the Royal Society B: Biological Sciences.2020; 375(1793): 20190135.     CrossRef
  • Prediction of muscle mass in arms and legs based on 3D laser-based photonic body scans’ standard dimensions in a homogenous sample of young men
    Cristine Cavegn, Frank Rühli, Nicole Bender, Kaspar Staub
    Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization.2020; 8(5): 562.     CrossRef
  • Thermogenesis in Adipose Tissue Activated by Thyroid Hormone
    Winifred W. Yau, Paul M. Yen
    International Journal of Molecular Sciences.2020; 21(8): 3020.     CrossRef
  • Interaction of a Sarcolipin Pentamer and Monomer with the Sarcoplasmic Reticulum Calcium Pump, SERCA
    John Paul Glaves, Joseph O. Primeau, Przemek A. Gorski, L. Michel Espinoza-Fonseca, M. Joanne Lemieux, Howard S. Young
    Biophysical Journal.2020; 118(2): 518.     CrossRef
  • Automated CT-derived skeletal muscle mass determination in lower hind limbs of mice using a 3D U-Net deep learning network
    Brent van der Heyden, Wouter R. P. H. van de Worp, Ardy van Helvoort, Jan Theys, Annemie M. W. J. Schols, Ramon C. J. Langen, Frank Verhaegen
    Journal of Applied Physiology.2020; 128(1): 42.     CrossRef
  • Modified creatinine index and risk for long-term infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-Cohort Study
    Hokuto Arase, Shunsuke Yamada, Hiroto Hiyamuta, Masatomo Taniguchi, Masanori Tokumoto, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono
    Scientific Reports.2020;[Epub]     CrossRef
  • Ticking for Metabolic Health: The Skeletal‐Muscle Clocks
    Miguel A. Gutierrez‐Monreal, Jan‐Frieder Harmsen, Patrick Schrauwen, Karyn A. Esser
    Obesity.2020;[Epub]     CrossRef
  • Gut microbiota and regulation of myokine-adipokine function
    Francesco Suriano, Matthias Van Hul, Patrice D Cani
    Current Opinion in Pharmacology.2020; 52: 9.     CrossRef
  • P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
    Roberto Coccurello, Cinzia Volonté
    Frontiers in Endocrinology.2020;[Epub]     CrossRef
  • Primary Active Ca2+ Transport Systems in Health and Disease
    Jialin Chen, Aljona Sitsel, Veronick Benoy, M. Rosario Sepúlveda, Peter Vangheluwe
    Cold Spring Harbor Perspectives in Biology.2020; 12(2): a035113.     CrossRef
  • Sex‐specific alterations in whole body energetics and voluntary activity in heterozygous R163C malignant hyperthermia‐susceptible mice
    Jennifer M. Rutkowsky, Trina A. Knotts, Paul D. Allen, Isaac N. Pessah, Jon J. Ramsey
    The FASEB Journal.2020; 34(6): 8721.     CrossRef
  • The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review
    Adrian M. Gonzalez-Gil, Leticia Elizondo-Montemayor
    Nutrients.2020; 12(6): 1899.     CrossRef
  • Emergent Coordination of the CHKB and CPT1B Genes in Eutherian Mammals: Implications for the Origin of Brown Adipose Tissue
    Bhavin V. Patel, Fanrong Yao, Aidan Howenstine, Risa Takenaka, Jacob A. Hyatt, Karen E. Sears, Brian M. Shewchuk
    Journal of Molecular Biology.2020; 432(23): 6127.     CrossRef
  • Chronic cold exposure induces mitochondrial plasticity in deer mice native to high altitudes
    Sajeni Mahalingam, Zachary A. Cheviron, Jay F. Storz, Grant B. McClelland, Graham R. Scott
    The Journal of Physiology.2020; 598(23): 5411.     CrossRef
  • Adaptive thermogenesis enhances the life-threatening response to heat in mice with an Ryr1 mutation
    Hui J. Wang, Chang Seok Lee, Rachel Sue Zhen Yee, Linda Groom, Inbar Friedman, Lyle Babcock, Dimitra K. Georgiou, Jin Hong, Amy D. Hanna, Joseph Recio, Jong Min Choi, Ting Chang, Nadia H. Agha, Jonathan Romero, Poonam Sarkar, Nicol Voermans, M. Waleed Gab
    Nature Communications.2020;[Epub]     CrossRef
  • Sclerostin Influences Exercise-Induced Adaptations in Body Composition and White Adipose Tissue Morphology in Male Mice
    Nigel Kurgan, Joshua Stoikos, Bradley J. Baranowski, Jenalyn Yumol, Roopan Dhaliwal, Jake B. Sweezey-Munroe, Val A. Fajardo, William Gittings, Rebecca E.K. Macpherson, Panagiota Klentrou
    Journal of Bone and Mineral Research.2020; 38(4): 541.     CrossRef
  • Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high‐fat‐diet‐induced pre‐diabetes
    Dengqiu Xu, Zhenzhou Jiang, Zeren Sun, Lu Wang, Guolin Zhao, Hozeifa M. Hassan, Sisi Fan, Wang Zhou, Shuangshuang Han, Luyong Zhang, Tao Wang
    Journal of Cellular Physiology.2019; 234(5): 7510.     CrossRef
  • Noninvasive and in vivo assessment of upper and lower limb skeletal muscle oxidative metabolism activity and microvascular responses to glucose ingestion in humans
    Rogério Nogueira Soares, Alessandro L. Colosio, Juan Manuel Murias, Silvia Pogliaghi
    Applied Physiology, Nutrition, and Metabolism.2019; 44(10): 1105.     CrossRef
  • Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization
    Xiaofang Chen, Shu Zhuo, Tengfei Zhu, Pengle Yao, Mengmei Yang, Hong Mei, Na Li, Fengguang Ma, Ji Ming Wang, Shiting Chen, Richard D. Ye, Yu Li, Yingying Le
    Diabetes.2019; 68(6): 1130.     CrossRef
  • Taurine protects against arsenic trioxide-induced insulin resistance via ROS-Autophagy pathway in skeletal muscle
    Lei Yang, Tianming Qiu, Xiaofeng Yao, Liping Jiang, Sen Wei, Pei Pei, Zhidong Wang, Jie Bai, Xiaofang Liu, Guang Yang, Shuang Liu, Xiance Sun
    The International Journal of Biochemistry & Cell Biology.2019; 112: 50.     CrossRef
  • Increased triacylglycerol - Fatty acid substrate cycling in human skeletal muscle cells exposed to eicosapentaenoic acid
    Nils G. Løvsletten, Siril S. Bakke, Eili T. Kase, D. Margriet Ouwens, G. Hege Thoresen, Arild C. Rustan, Juan J. Loor
    PLOS ONE.2018; 13(11): e0208048.     CrossRef
  • Transient receptor potential (TRP) channels: a metabolic TR(i)P to obesity prevention and therapy
    M. Bishnoi, P. Khare, L. Brown, S. K. Panchal
    Obesity Reviews.2018; 19(9): 1269.     CrossRef
  • Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
    Shreekrishna Lamichane, Babita Dahal Lamichane, Sang-Mo Kwon
    International Journal of Molecular Sciences.2018; 19(4): 949.     CrossRef
  • Antiobesity Effect ofAstilbe chinensisFranch. et Savet. Extract through Regulation of Adipogenesis and AMP-Activated Protein Kinase Pathways in 3T3-L1 Adipocyte and High-Fat Diet-Induced C57BL/6N Obese Mice
    Xian Hua Zhang, Zhiqiang Wang, Bueom-Goo Kang, Seung Hwan Hwang, Jae-Young Lee, Soon Sung Lim, Bo Huang
    Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1.     CrossRef
  • Loss of P2X7 receptor function dampens whole body energy expenditure and fatty acid oxidation
    Giacomo Giacovazzo, Savina Apolloni, Roberto Coccurello
    Purinergic Signalling.2018; 14(3): 299.     CrossRef
  • Chromatin and Metabolism
    Tamaki Suganuma, Jerry L. Workman
    Annual Review of Biochemistry.2018; 87(1): 27.     CrossRef
  • Zebrafish as a Model for Obesity and Diabetes
    Liqing Zang, Lisette A. Maddison, Wenbiao Chen
    Frontiers in Cell and Developmental Biology.2018;[Epub]     CrossRef
  • Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass
    Seo Lee, Soyeon Ahn, Young Kim, Myoung Ji, Kyoung Kim, Sung Choi, Hak Jang, Soo Lim
    Nutrients.2018; 10(6): 738.     CrossRef
Clinical Diabetes & Therapeutics
Monotherapy in Patients with Type 2 Diabetes Mellitus
Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
Diabetes Metab J. 2017;41(5):349-356.   Published online October 19, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.349
  • 5,634 View
  • 70 Download
  • 12 Web of Science
  • 12 Crossref
AbstractAbstract PDFPubReader   

In order to improve the quality of life and to prevent chronic complications related to diabetes mellitus, intensive lifestyle modification and proper medication are needed from the early stage of diagnosis of type 2 diabetes mellitus (T2DM). When using the first medication for diabetic patients, the appropriate treatment should be selected considering the clinical characteristics of the patient, efficacy of the drug, side effects, and cost. In general, the use of metformin as the first treatment for oral hypoglycemic monotherapy is recommended because of its excellent blood glucose-lowering effect, relatively low side effects, long-term proven safety, low risk of hypoglycemia, and low weight gain. If metformin is difficult to use as a first-line treatment, other appropriate medications should be selected in view of the clinical situation. If the goal of achieving glycemic control is not achieved by monotherapy, a combination therapy with different mechanisms of action should be initiated promptly.

Citations

Citations to this article as recorded by  
  • Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms
    Pranay Wal, Jyotsana Dwivedi, Ankita Wal, Shivangi Kushwaha
    Current Diabetes Reviews.2023;[Epub]     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Synthesis, antidiabetic activity and molecular docking study of rhodanine-substitued spirooxindole pyrrolidine derivatives as novel α-amylase inhibitors
    Amani Toumi, Sarra Boudriga, Khaled Hamden, Mansour Sobeh, Mohammed Cheurfa, Moheddine Askri, Michael Knorr, Carsten Strohmann, Lukas Brieger
    Bioorganic Chemistry.2021; 106: 104507.     CrossRef
  • Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
    Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
    Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
  • Type II diabetes mellitus: a review on recent drug based therapeutics
    Santwana Padhi, Amit Kumar Nayak, Anindita Behera
    Biomedicine & Pharmacotherapy.2020; 131: 110708.     CrossRef
  • Comparison of the effects of gemigliptin and dapagliflozin on glycaemic variability in type 2 diabetes: A randomized, open‐label, active‐controlled, 12‐week study (STABLE II study)
    Soo Heon Kwak, You‐Cheol Hwang, Jong Chul Won, Ji Cheol Bae, Hyun Jin Kim, Sunghwan Suh, Eun Young Lee, Subin Lee, Sang‐Yong Kim, Jae Hyeon Kim
    Diabetes, Obesity and Metabolism.2020; 22(2): 173.     CrossRef
  • Metabolomics approach to identify the active substances influencing the antidiabetic activity of Lagerstroemia species
    Mun-Ock Kim, Su Ui Lee, Heung Joo Yuk, Hyun-Jae Jang, Jae-Won Lee, Eun-Bin Kwon, Jin-Hyub Paik, SangHo Choi, Adek Nizar, Tran The Bach, Kongmany Sydara, Hang Jin, So-Yeun Woo, Sei-Ryang Oh, Hyung Won Ryu
    Journal of Functional Foods.2020; 64: 103684.     CrossRef
  • Cardiometabolic diseases and active aging - polypharmacy in control
    Adriana Nancy Medeiros dos Santos, Dulcineia Rebecca Cappelletti Nogueira, Beatriz Aparecida Ozello Gutierrez, Rosa Yuka Sato Chubaci, Caroline Ribeiro de Borja Oliveira
    Revista Brasileira de Enfermagem.2020;[Epub]     CrossRef
  • Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice
    Chang Yang, Qi Feng, Huan Liao, Xinlei Yu, Yang Liu, Di Wang
    International Journal of Molecular Sciences.2019; 20(20): 5205.     CrossRef
  • Specific PERK inhibitors enhanced glucose-stimulated insulin secretion in a mouse model of type 2 diabetes
    Min Joo Kim, Mi Na Kim, Se Hee Min, Dong-Sik Ham, Ji-Won Kim, Kun-Ho Yoon, Kyong Soo Park, Hye Seung Jung
    Metabolism.2019; 97: 87.     CrossRef
  • A randomized, open‐label, multicentre, parallel‐controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti
    Lixin Guo, Li Chen, Baocheng Chang, Liyong Yang, Yu Liu, Bo Feng
    Diabetes, Obesity and Metabolism.2018; 20(12): 2740.     CrossRef
  • Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
    Sang Youl Rhee
    The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef
Clinical Diabetes & Therapeutics
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
Diabetes Metab J. 2017;41(5):337-348.   Published online October 17, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.5.337
  • 7,096 View
  • 64 Download
  • 38 Web of Science
  • 45 Crossref
AbstractAbstract PDFPubReader   

In 2017, the Korean Diabetes Association (KDA) published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). The KDA regularly updates its Clinical Practice Guidelines, but since the last update in 2015, many results from clinical trials have been introduced, and domestic data from studies performed in Korean patients with T2DM have been published. Recently, evidence from large clinical studies assessing cardiovascular outcomes following the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in patients with T2DM were incorporated into the recommendations. Additionally, new data from clinical trials using dipeptidyl peptidase 4 inhibitors and thiazolidinediones in Korean patients with T2DM were added. Following a systematic review and assessment of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the use of antihyperglycemic agents and revised the treatment algorithm for Korean adult patients with T2DM.

Citations

Citations to this article as recorded by  
  • Comparative Study on Efficacy of Empagliflozin Versus Sitagliptin, as an Add-on Therapy to Metformin in Type 2 Diabetic Patients
    Harsh Salankar, Sonali Rode, C. Arjun, Rajeeta Joseph, Gourav B. Deshmane, Radhika P. Vijayan
    Journal of Pharmacy and Bioallied Sciences.2024; 16(Suppl 1): S335.     CrossRef
  • Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients
    Young-Hwan Park, Minji Sohn, So Yeon Lee, Soo Lim
    Diabetes & Metabolism Journal.2024; 48(2): 253.     CrossRef
  • Association of preoperative blood glucose level with delirium after non-cardiac surgery in diabetic patients
    Soo Jung Park, Ah Ran Oh, Jong-Hwan Lee, Kwangmo Yang, Jungchan Park
    Korean Journal of Anesthesiology.2024; 77(2): 226.     CrossRef
  • Systematic review and meta-analysis of teneligliptin for treatment of type 2 diabetes
    R. Pelluri, S. Kongara, V. R. Nagasubramanian, S. Mahadevan, J. Chimakurthy
    Journal of Endocrinological Investigation.2023; 46(5): 855.     CrossRef
  • Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
    Hyeong Kyu Park, Kyoung‐Ah Kim, Kyung‐Wan Min, Tae‐Seo Sohn, In Kyung Jeong, Chul Woo Ahn, Nan‐Hee Kim, Ie Byung Park, Ho Chan Cho, Choon Hee Chung, Sung Hee Choi, Kang Seo Park, Seoung‐Oh Yang, Kwan Woo Lee
    Diabetes, Obesity and Metabolism.2023; 25(9): 2743.     CrossRef
  • Paradigm Shift in Management of Hyperglycemia in Patients with Type 2 Diabetes: Glucocentric versus Organ Protection
    Jong Chul Won
    The Journal of Korean Diabetes.2023; 24(2): 59.     CrossRef
  • A Comparison of the Effects of Empagliflozin and Sitagliptin, When Combined With Metformin, on Lipid Levels in Patients with Type 2 Diabetes: A Clinical Investigation
    Mazhar Ahmed, Asjad Saeed, Muhammad Zarar Khan, Sana Z Javaid, Farhan Aslam, Savida Ilyas Dar
    Cureus.2023;[Epub]     CrossRef
  • Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extensio
    Jun Sung Moon, Il Rae Park, Hae Jin Kim, Choon Hee Chung, Kyu Chang Won, Kyung Ah Han, Cheol-Young Park, Jong Chul Won, Dong Jun Kim, Gwan Pyo Koh, Eun Sook Kim, Jae Myung Yu, Eun-Gyoung Hong, Chang Beom Lee, Kun-Ho Yoon
    Diabetes & Metabolism Journal.2023; 47(6): 808.     CrossRef
  • Efficacy and Safety of Mulberry Twig Alkaloids Tablet for Treatment of Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Multicenter Clinical Study
    Ling Qu, Xiao-chun Liang, Guo-qing Tian, Gai-li Zhang, Qun-li Wu, Xiu-mei Huang, Ya-zhong Cui, Yu-ling Liu, Zhu-fang Shen, Guo-qing Ma, Hao Lu, Yi Li, Hong Jiang, Xi-yan Yang, Guang-de Zhang, Chen-hua Yang
    Chinese Journal of Integrative Medicine.2022; 28(4): 304.     CrossRef
  • Risk for Imbalanced Blood Glucose Pattern: Construct Analysis and Nursing Diagnosis Proposal
    Rafael Oliveira Pitta Lopes, Jéssica de Castro Santos, Hudson Carmo de Oliveira, Juliana Faria Campos, Cândida Caniçali Primo, Camila Takáo Lopes, Marcos Antônio Gomes Brandão
    Clinical Nursing Research.2022; 31(7): 1241.     CrossRef
  • Long‐term clinical outcomes of oral antidiabetic drugs as fixed‐dose combinations: A nationwide retrospective cohort study
    Sang‐Jun Cho, In‐Sun Oh, Han Eol Jeong, Young Min Cho, Yul Hwangbo, Oriana Hoi Yun Yu, Ju‐Young Shin
    Diabetes, Obesity and Metabolism.2022; 24(10): 2051.     CrossRef
  • Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients
    Muaz Mubashir, Mazhar Ahmed, Hassan Atique, Ahmed Wassan, Mehdi Naqvi, Muneeb Ullah
    Cureus.2022;[Epub]     CrossRef
  • The Mediating Effect of Acceptance Action in the Relationship between Diabetes Distress and Self-stigma among Old Adults with Diabetes in South Korea
    Hyesun Kim, Kawoun Seo
    Journal of Korean Academy of Community Health Nursing.2022; 33(4): 446.     CrossRef
  • Increasing Individual Target Glucose Levels to Prevent Hypoglycemia in Patients with Diabetes
    Juyoung Shin, Hyunah Kim, Hun-Sung Kim, Churlmin Kim, Whan-Seok Choi
    Korean Journal of Family Medicine.2021; 42(4): 269.     CrossRef
  • Phase III, randomized, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of teneligliptin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise
    Linong Ji, Jianhua Ma, Weiping Lu, Jingdong Liu, Jiao’e Zeng, Jialin Yang, Wei Li, Xiuzhen Zhang, Xinhua Xiao, Gen Takayanagi, Yi Wang
    Journal of Diabetes Investigation.2021; 12(4): 537.     CrossRef
  • Umbilical Cord-Mesenchymal Stem Cell-Conditioned Medium Improves Insulin Resistance in C2C12 Cell
    Kyung-Soo Kim, Yeon Kyung Choi, Mi Jin Kim, Jung Wook Hwang, Kyunghoon Min, Sang Youn Jung, Soo-Kyung Kim, Yong-Soo Choi, Yong-Wook Cho
    Diabetes & Metabolism Journal.2021; 45(2): 260.     CrossRef
  • Blood glucose levels and bodyweight change after dapagliflozin administration
    Hyunah Kim, Seung‐Hwan Lee, Hyunyong Lee, Hyeon Woo Yim, Jae‐Hyoung Cho, Kun‐Ho Yoon, Hun‐Sung Kim
    Journal of Diabetes Investigation.2021; 12(9): 1594.     CrossRef
  • Effects of liraglutide combined with metformin and Diamicron on glucose–lipid metabolism and islet β-cell function in elderly patients with type 2 diabetes mellitus
    Chunzhi Zhao, Xing Li, Jianhua Ma, Zhengtai Zhu, Hua Li, Fangli Lou, Yuefang Zhai, Hui Chen, Shujun Xiao, Qinhui Peng, Huilian Hua, Qing Zhang, Fangyong Lou
    All Life.2021; 14(1): 333.     CrossRef
  • Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
    Ling Qu, Xiaochun Liang, Guoqing Tian, Gaili Zhang, Qunli Wu, Xiumei Huang, Yazhong Cui, Yuling Liu, Zhufang Shen, Changqing Xiao, Yingfen Qin, Heng Miao, Yongyan Zhang, Ziling Li, Shandong Ye, Xuezhi Zhang, Jing Yang, Guiwen Cao, Yi Li, Gangyi Yang, Ji H
    Diabetes Care.2021; 44(6): 1324.     CrossRef
  • Clinical Impact of Combination Therapy in Diabetic Neuropathy and Nephropathy
    Harmeet Kaur, Arvinder Kaur, Pankaj Kumar Prashar, Anamika Gautam, Ankita Sood, Sachin Kumar Singh, Monica Gulati, Narendra Kumar Pandey, Bimlesh Kumar
    Research Journal of Pharmacy and Technology.2021; : 3471.     CrossRef
  • Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label Trial
    Da Young Lee, Seung-Hyun Yoo, Kyong Pil Min, Cheol-Young Park
    JMIR mHealth and uHealth.2020; 8(9): e19153.     CrossRef
  • Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
    Diabetes & Metabolism Journal.2020; 44(3): 382.     CrossRef
  • Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
    Jeong Mi Kim, Sang Soo Kim, Jong Ho Kim, Mi Kyung Kim, Tae Nyun Kim, Soon Hee Lee, Chang Won Lee, Ja Young Park, Eun Sook Kim, Kwang Jae Lee, Young Sik Choi, Duk Kyu Kim, In Joo Kim
    Diabetes & Metabolism Journal.2020; 44(1): 67.     CrossRef
  • Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes
    Sang Ouk Chin, In Gyoon Ha, Sang Youl Rhee, Su Jin Jeong, Suk Chon, Sung Hoon Kim, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Jeong Taek Woo
    International Journal of Endocrinology.2020; 2020: 1.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonist Differentially Affects Brain Activation in Response to Visual Food Cues in Lean and Obese Individuals with Type 2 Diabetes Mellitus
    Jae Hyun Bae, Hyung Jin Choi, Kang Ik Kevin Cho, Lee Kyung Kim, Jun Soo Kwon, Young Min Cho
    Diabetes & Metabolism Journal.2020; 44(2): 248.     CrossRef
  • Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects


    Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, SeungHwan Lee
    Drug Design, Development and Therapy.2020; Volume 14: 5179.     CrossRef
  • Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
    Yun Kyung Cho, Jiwoo Lee, Yu Mi Kang, Jee Hee Yoo, Joong-Yeol Park, Chang Hee Jung, Woo Je Lee, Tatsuo Shimosawa
    PLOS ONE.2019; 14(8): e0220667.     CrossRef
  • Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double‐blind, non‐inferiority trial
    Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan‐Hee Kim, Kyung Mook Choi, Sung‐Rae Kim, JiYoung You, Se‐Jin Kim, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2019; 21(3): 631.     CrossRef
  • Pharmacotherapy of Diabetes Focused on Stroke
    Young-Sang Lyu, Jin-Hwa Kim, Sang-Yong Kim
    Journal of the Korean Neurological Association.2019; 37(3): 235.     CrossRef
  • Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2019;43;276-86)
    Hannah Seok, Tae Seo Sohn
    Diabetes & Metabolism Journal.2019; 43(4): 545.     CrossRef
  • Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors
    Minyoung Lee, Jiyu Sun, Minkyung Han, Yongin Cho, Ji-Yeon Lee, Chung Mo Nam, Eun Seok Kang
    Diabetes Care.2019; 42(11): 2057.     CrossRef
  • Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Tae Jung Oh, Jae Myung Yu, Kyung Wan Min, Hyun Shik Son, Moon Kyu Lee, Kun Ho Yoon, Young Duk Song, Joong Yeol Park, In Kyung Jeong, Bong Soo Cha, Yong Seong Kim, Sei Hyun Baik, In Joo Kim, Doo Man Kim, Sung Rae Kim, Kwan Woo Lee, Jeong Hyung Park, In Kyu
    Diabetes & Metabolism Journal.2019; 43(3): 276.     CrossRef
  • 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea
    Mee Kyoung Kim, Seung-Hyun Ko, Bo-Yeon Kim, Eun Seok Kang, Junghyun Noh, Soo-Kyung Kim, Seok-O Park, Kyu Yeon Hur, Suk Chon, Min Kyong Moon, Nan-Hee Kim, Sang Yong Kim, Sang Youl Rhee, Kang-Woo Lee, Jae Hyeon Kim, Eun-Jung Rhee, SungWan Chun, Sung Hoon Yu
    Diabetes & Metabolism Journal.2019; 43(4): 398.     CrossRef
  • Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
    Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
    Endocrinology and Metabolism.2019; 34(4): 349.     CrossRef
  • Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
    Sang Youl Rhee
    The Journal of Korean Diabetes.2018; 19(1): 15.     CrossRef
  • Glucose Control in Intensive Care Unit Patients: Recent Updates
    Sang Youl Rhee
    Journal of Neurocritical Care.2018; 11(2): 81.     CrossRef
  • Educational Strategies for Insulin Injection Therapy in Elderly Diabetic Patients
    Eun Chong Shin
    The Journal of Korean Diabetes.2018; 19(2): 101.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Hyun Jin Kim
    The Journal of Korean Diabetes.2018; 19(1): 35.     CrossRef
  • Fifty Years of Compassionate Care and Harmonious Collaboration of the Korean Diabetes Association: The 50th Anniversary of Korean Diabetes Association
    Jong Chul Won, Eun-Jung Rhee, Hyung Joon Yoo
    Diabetes & Metabolism Journal.2018; 42(6): 475.     CrossRef
  • Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
    Kyung‐Ah Han, Suk Chon, Choon Hee Chung, Soo Lim, Kwan‐Woo Lee, SeiHyun Baik, Chang Hee Jung, Dong‐Sun Kim, Kyong Soo Park, Kun‐Ho Yoon, In‐Kyu Lee, Bong‐Soo Cha, Taishi Sakatani, Sumi Park, Moon‐Kyu Lee
    Diabetes, Obesity and Metabolism.2018; 20(10): 2408.     CrossRef
  • Monotherapy in Patients with Type 2 Diabetes Mellitus
    Sang Youl Rhee, Hyun Jin Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Kyung Mook Choi, Jin Hwa Kim
    Diabetes & Metabolism Journal.2017; 41(5): 349.     CrossRef
  • Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
    The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
  • New anti-diabetic agents
    Doo-Man Kim
    Journal of the Korean Medical Association.2017; 60(12): 992.     CrossRef
  • Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
    Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi
    Diabetes & Metabolism Journal.2017; 41(6): 423.     CrossRef
  • Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
    Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
    Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef
Clinical Diabetes & Therapeutics
The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis
Jinyue Yu, Peige Song, Rachel Perry, Chris Penfold, Ashley R. Cooper
Diabetes Metab J. 2017;41(4):251-262.   Published online August 22, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.4.251
  • 7,421 View
  • 115 Download
  • 47 Web of Science
  • 51 Crossref
AbstractAbstract PDFPubReader   

Green tea or green tea extract (GT/GTE) has been demonstrated to reduce insulin resistance and improve glycemic control. However, evidence for this health beneficial effect is inconsistent. This systematic review evaluated the effect of GT/GTE on insulin resistance and glycemic control in people with pre-diabetes/type 2 diabetes mellitus (T2DM). Ovid MEDLINE, Embase, AMED, Web of Science, and the Cochrane Library were searched up to April 2017 for randomised controlled trials of participants with pre-diabetes or T2DM, where the intervention was GT/GTE. Meta-analysis was performed to assess the standardised mean difference (SMD) in biomarkers of insulin resistance and glycemic control between GT/GTE and placebo groups. Six studies (n=382) were pooled into random-effects meta-analysis. Overall, no differences were found between GT/GTE and the placebo for glycosylated hemoglobin (HbA1c: SMD, −0.32; 95% confidence interval [CI], −0.86 to 0.23), homeostatic model assessment for insulin resistance (HOMA-IR: SMD, 0.10; 95% CI, −0.17 to 0.38), fasting insulin (SMD, −0.25; 95% CI, −0.64 to 0.15), and fasting glucose (SMD, −0.10; 95% CI, −0.50 to 0.30). No evidence support the consumption of GT/GTE could reduce the levels of HbA1c, HOMA-IR, fasting insulin, or fasting glucose in people with pre-diabetes/T2DM. However, the studies included were small and of varying quality.

Citations

Citations to this article as recorded by  
  • Is breakfast consumption detrimental, unnecessary, or an opportunity for health promotion? A review of cardiometabolic outcomes and functional food choices
    Heitor O. Santos, Grant M. Tinsley
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • A comparison of the effects of green tea and cocoa on glycaemic control and insulin sensitivity in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
    Hind Mesfer S. Alkhudaydi, Jeremy P.E. Spencer
    Nutrition and Healthy Aging.2024; 9(1): 17.     CrossRef
  • Association between green tea intake and digestive system cancer risk in European and East Asian populations: a Mendelian randomization study
    Duorui Nie, Xiaoyu He, Hao Zheng, Deyu Deng, Fanghui He, Ruyi Li, Xiaoting Ni, Shunxiang Li, Fei Xu
    European Journal of Nutrition.2024;[Epub]     CrossRef
  • From Gut to Glucose: A Comprehensive Review on Functional Foods and Dietary Interventions for Diabetes Management
    Nirali Patel, Susha Dinesh, Sameer Sharma
    Current Diabetes Reviews.2024;[Epub]     CrossRef
  • Gut microbiota as a driver of the interindividual variability of cardiometabolic effects from tea polyphenols
    Qiqiong Li, Tom Van de Wiele
    Critical Reviews in Food Science and Nutrition.2023; 63(11): 1500.     CrossRef
  • Recent insights on tea metabolites, their biosynthesis and chemo-preventing effects: A review
    Ramkumar Samynathan, Muthu Thiruvengadam, Shivraj Hariram Nile, Mohammad Ali Shariati, Maksim Rebezov, Raghvendra Kumar Mishra, Baskar Venkidasamy, Sureshkumar Periyasamy, Ill-Min Chung, Mirian Pateiro, José M. Lorenzo
    Critical Reviews in Food Science and Nutrition.2023; 63(18): 3130.     CrossRef
  • Tea's anti‐obesity properties, cardiometabolic health‐promoting potentials, bioactive compounds, and adverse effects: A review focusing on white and green teas
    Behnaz Abiri, Shirin Amini, Mahdi Hejazi, Farhad Hosseinpanah, Afshin Zarghi, Faeze Abbaspour, Majid Valizadeh
    Food Science & Nutrition.2023; 11(10): 5818.     CrossRef
  • An investigation into the potential action of polyphenols against human Islet Amyloid Polypeptide aggregation in type 2 diabetes
    Anns Mahboob, Degiri Kalana Lasanga Senevirathne, Pradipta Paul, Faisal Nabi, Rizwan Hasan Khan, Ali Chaari
    International Journal of Biological Macromolecules.2023; 225: 318.     CrossRef
  • Association between green tea consumption and metabolic syndrome among Korean adults: results from the Health Examinees study
    Hyeonjin Cho, Sunwoo Han, Jiwon Jeong, Hyein Jung, Sangah Shin
    Journal of Nutrition and Health.2023; 56(1): 70.     CrossRef
  • Relevance of Indian traditional tisanes in the management of type 2 diabetes mellitus: A review
    Devi Datt Joshi, Lokesh Deb, Bharat G. Somkuwar, Virendra Singh Rana
    Saudi Pharmaceutical Journal.2023; 31(5): 626.     CrossRef
  • Evaluation the Effect of Chronic Obestatin Therapy on the Serum Glucose, Insulin And Lipid Levels in Type 2 Diabetic Rats
    Safa Al-Halbouni, Shadi Homsi, Nabil koshji
    The Open Public Health Journal.2023;[Epub]     CrossRef
  • Supplementation with a New Standardized Extract of Green and Black Tea Exerts Antiadipogenic Effects and Prevents Insulin Resistance in Mice with Metabolic Syndrome
    Mario De la Fuente-Muñoz, María De la Fuente-Fernández, Marta Román-Carmena, Sara Amor, María C. Iglesias-de la Cruz, Guillermo García-Laínez, Silvia Llopis, Patricia Martorell, David Verdú, Eva Serna, Ángel L. García-Villalón, Sonia I. Guilera, Antonio M
    International Journal of Molecular Sciences.2023; 24(10): 8521.     CrossRef
  • The effect of green tea supplementation on the anthropometric outcomes in overweight and obese women: a time and dose-response meta-analysis of randomized controlled trials
    Yiyi Zhang, Nie Tang, Wei Xia, Shaikh Sanjid Seraj, Marcos Pereira, Periyannan Velu, Hui Zhou, Hanshu Yang, Guanggang Du
    Critical Reviews in Food Science and Nutrition.2023; : 1.     CrossRef
  • Ampelopsis grossedentata improves type 2 diabetes mellitus through modulating the gut microbiota and bile acid metabolism
    Yu-li Hu, Mei Li, Lei Ding, Chuan Peng, You Wu, Wei Liu, Dan Zhao, Ling-ling Qin, Xiang-yu Guo, Li-li Wu, Tong-hua Liu
    Journal of Functional Foods.2023; 107: 105622.     CrossRef
  • Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathways Amelioration in Metabolic Syndrome Rat Model
    Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
    F1000Research.2023; 10: 990.     CrossRef
  • Impact of Polyphenols on Inflammatory and Oxidative Stress Factors in Diabetes Mellitus: Nutritional Antioxidants and Their Application in Improving Antidiabetic Therapy
    Michal Krawczyk, Izabela Burzynska-Pedziwiatr, Lucyna A. Wozniak, Malgorzata Bukowiecka-Matusiak
    Biomolecules.2023; 13(9): 1402.     CrossRef
  • Research progress on the antidiabetic activities of tea and its bioactive components
    Jianjian Gao, Dan Chen, Zhiyuan Lin, Jiakun Peng, Shuai Yu, Chuang Zhou, Huimin Jiang, Ruofan Sun, Zhi Lin, Weidong Dai
    Beverage Plant Research.2023;[Epub]     CrossRef
  • Identifying Glucose Metabolism Status in Nondiabetic Japanese Adults Using Machine Learning Model with Simple Questionnaire
    Tomoki Uchida, Takeshi Kanamori, Takanori Teramoto, Yuji Nonaka, Hiroki Tanaka, Satoshi Nakamura, Norihito Murayama, Rajesh Kaluri
    Computational and Mathematical Methods in Medicine.2022; 2022: 1.     CrossRef
  • Potential Bioactive Components and Health Promotional Benefits of Tea (Camellia sinensis)
    Saptadip Samanta
    Journal of the American Nutrition Association.2022; 41(1): 65.     CrossRef
  • A Mendelian Randomization Study of the Effect of Tea Intake on Type 2 Diabetes
    Yanan Zhang, Ruiqing Wang, Xinhua Tang, Yanjun Wang, Ping Guo, Shukang Wang, Jing Liu
    Frontiers in Genetics.2022;[Epub]     CrossRef
  • Dietary Supplements for Weight Management: A Narrative Review of Safety and Metabolic Health Benefits
    Eunice Mah, Oliver Chen, DeAnn J. Liska, Jeffrey B. Blumberg
    Nutrients.2022; 14(9): 1787.     CrossRef
  • Antioxidative, Anti-Inflammatory, Anti-Obesogenic, and Antidiabetic Properties of Tea Polyphenols—The Positive Impact of Regular Tea Consumption as an Element of Prophylaxis and Pharmacotherapy Support in Endometrial Cancer
    Piotr Olcha, Anna Winiarska-Mieczan, Małgorzata Kwiecień, Łukasz Nowakowski, Andrzej Miturski, Andrzej Semczuk, Bożena Kiczorowska, Krzysztof Gałczyński
    International Journal of Molecular Sciences.2022; 23(12): 6703.     CrossRef
  • Herbal tea, a novel adjuvant therapy for treating type 2 diabetes mellitus: A review
    Xiangyuan Zhang, Lili Zhang, Boxun Zhang, Ke Liu, Jun Sun, Qingwei Li, Linhua Zhao
    Frontiers in Pharmacology.2022;[Epub]     CrossRef
  • Green tea and cancer and cardiometabolic diseases: a review of the current epidemiological evidence
    Sarah Krull Abe, Manami Inoue
    European Journal of Clinical Nutrition.2021; 75(6): 865.     CrossRef
  • Green and white teas as health-promoting foods
    Daniel Hinojosa-Nogueira, Sergio Pérez-Burillo, Silvia Pastoriza de la Cueva, José Ángel Rufián-Henares
    Food & Function.2021; 12(9): 3799.     CrossRef
  • A systematic review and meta-analysis of association between brain-derived neurotrophic factor and type 2 diabetes and glycemic profile
    Milad Davarpanah, Nafiseh Shokri-mashhadi, Rahele Ziaei, Parvane Saneei
    Scientific Reports.2021;[Epub]     CrossRef
  • Maltodextrin encapsulation improves thermal and pH stability of green tea extract catechins
    Aimara V. De La Cruz‐Molina, Jesus F. Ayala Zavala, Ariadna T. Bernal Mercado, Manuel R. Cruz Valenzuela, Gustavo A. González‐Aguilar, Jaime Lizardi‐Mendoza, Francisco Brown‐Bojorquez, Brenda A. Silva‐Espinoza
    Journal of Food Processing and Preservation.2021;[Epub]     CrossRef
  • Camellia sinensis in Dentistry: Technological Prospection and Scientific Evidence
    Lídia Audrey Rocha Valadas, Rosueti Diógenes de Oliveira Filho, Edilson Martins Rodrigues Neto, Mary Anne Medeiros Bandeira, Marta Maria de França Fonteles, Vanara Florêncio Passos, Ana Cristina de Mello Fiallos, Mara Assef Leitao Lotif, Nara Juliana Cust
    Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
  • A comprehensive insight into effects of green tea extract in polycystic ovary syndrome: a systematic review
    Vahid Maleki, Ehsaneh Taheri, Parisa Varshosaz, Fatemeh Pourteymour Fard Tabrizi, Jalal Moludi, Hamed Jafari-Vayghan, Mahdi Shadnoush, Seyed Hossein Yahyazadeh Jabbari, Mehri Seifoleslami, Mohammad Alizadeh
    Reproductive Biology and Endocrinology.2021;[Epub]     CrossRef
  • Green Tea and Decaffeinated Light Roasted Green Coffee Extract Combination Improved Cardiac Insulin Resistance through Free Fatty Acids and Adiponectin/FAS Pathway Amelioration in Metabolic Syndrome Rat Model
    Mifetika Lukitasari, Mohammad Saifur Rohman, Dwi Adi Nugroho, Mukhamad Nur Kholis, Nila Aisyah Wahyuni, Nashi Widodo
    F1000Research.2021; 10: 990.     CrossRef
  • Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review
    Tina Nie, Garth J. S. Cooper
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • Green tea and selenium-enriched green tea ameliorates non-alcoholic fatty liver disease through peripheral 5-hydroxytryptamine signals in high-fat diet-fed mice
    Lin Zhang, Jia-Ying Xu, Ya-Fang Du, Zhang-Min Wang, Jian-Xiang Li, N. Ou-Yang, Yan Wang, Xue-Bin Yin, Li-Qiang Qin
    International Food Research Journal.2021; 28(5): 996.     CrossRef
  • Green Tea Consumption May Be Associated with Cardiovascular Disease Risk and Nonalcoholic Fatty Liver Disease in Type 2 Diabetics: A Cross-Sectional Study in Southeast China
    Huan-Huan Yang, Hui Zhou, Wan-Zhan Zhu, Cai-Long Chen, Guo-Chong Chen, Lu-Gang Yu, Li-Qiang Qin
    Journal of Medicinal Food.2020; 23(10): 1120.     CrossRef
  • The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies
    Omid Nikpayam, Amir Hossein Faghfouri, Omid Mohammad Tavakoli-Rouzbehani, Seyyed-Mostafa Jalali, Marziyeh Najafi, Golbon Sohrab
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(5): 1521.     CrossRef
  • Biological fates of tea polyphenols and their interactions with microbiota in the gastrointestinal tract: implications on health effects
    Tingting Chen, Chung S. Yang
    Critical Reviews in Food Science and Nutrition.2020; 60(16): 2691.     CrossRef
  • Effects of Timing of Acute and Consecutive Catechin Ingestion on Postprandial Glucose Metabolism in Mice and Humans
    Masaki Takahashi, Mamiho Ozaki, Miku Tsubosaka, Hyeon-Ki Kim, Hiroyuki Sasaki, Yuji Matsui, Masanobu Hibi, Noriko Osaki, Masashi Miyashita, Shigenobu Shibata
    Nutrients.2020; 12(2): 565.     CrossRef
  • Green tea (Camellia sinensis) for the prevention of cancer
    Tommaso Filippini, Marcella Malavolti, Francesca Borrelli, Angelo A Izzo, Susan J Fairweather-Tait, Markus Horneber, Marco Vinceti
    Cochrane Database of Systematic Reviews.2020;[Epub]     CrossRef
  • Metabolic Impact of Flavonoids Consumption in Obesity: From Central to Peripheral
    Viviana Sandoval, Hèctor Sanz-Lamora, Giselle Arias, Pedro F. Marrero, Diego Haro, Joana Relat
    Nutrients.2020; 12(8): 2393.     CrossRef
  • Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate
    Amir M. Al Hroob, Mohammad H. Abukhalil, Omnia E. Hussein, Ayman M. Mahmoud
    Biomedicine & Pharmacotherapy.2019; 109: 2155.     CrossRef
  • Effects and Mechanisms of Tea for the Prevention and Management of Diabetes Mellitus and Diabetic Complications: An Updated Review
    Jin-Ming Meng, Shi-Yu Cao, Xin-Lin Wei, Ren-You Gan, Yuan-Feng Wang, Shu-Xian Cai, Xiao-Yu Xu, Pang-Zhen Zhang, Hua-Bin Li
    Antioxidants.2019; 8(6): 170.     CrossRef
  • Improvement in fasting blood sugar, anthropometric measurement and hs-CRP after consumption of epigallocatechin-3-gallate (EGCG) in patients with type 2 diabetes mellitus
    Said Hadi, Meysam Alipour, Vahideh Aghamohammadi, Sahar Shahemi, Fatemeh Ghafouri-Taleghani, Niloufar Pourjavidi, Mona Foroughi, Mackaan Chraqipoor
    Nutrition & Food Science .2019; 50(2): 348.     CrossRef
  • The Phosphorylation of IRS1S307 and AktS473 Molecules in Insulin‐Resistant C2C12 Cells Induced with Palmitate Is Influenced by Epigallocatechin Gallate from Green Tea
    Salar Bakhtiyari, Motahareh Zaherara, Karimeh Haghani, Mehrdad Khatami, Ali Rashidinejad
    Lipids.2019; 54(2-3): 141.     CrossRef
  • Effect of annatto-extracted tocotrienols and green tea polyphenols on glucose homeostasis and skeletal muscle metabolism in obese male mice
    Eunhee Chung, Salvatore N. Campise, Hayli E. Joiner, Michael D. Tomison, Gurvinder Kaur, Jannette M. Dufour, Lillian Cole, Latha Ramalingam, Naima Moustaid-Moussa, Chwan-Li Shen
    The Journal of Nutritional Biochemistry.2019; 67: 36.     CrossRef
  • Studies on the Prevention of Cancer and Cardiometabolic Diseases by Tea: Issues on Mechanisms, Effective Doses, and Toxicities
    Chung S. Yang, Jinsong Zhang
    Journal of Agricultural and Food Chemistry.2019; 67(19): 5446.     CrossRef
  • Salvianolic acid B plays an anti-obesity role in high fat diet-induced obese mice by regulating the expression of mRNA, circRNA, and lncRNA
    Tian An, Jing Zhang, Bohan Lv, Yufei Liu, Jiangpinghao Huang, Juan Lian, Yanxiang Wu, Sihua Gao, Guangjian Jiang
    PeerJ.2019; 7: e6506.     CrossRef
  • Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism
    Kamesh Venkatakrishnan, Hui-Fang Chiu, Chin-Kun Wang
    Journal of Functional Foods.2019; 57: 425.     CrossRef
  • Green Tea Polyphenols Modify the Gut Microbiome in db/db Mice as Co‐Abundance Groups Correlating with the Blood Glucose Lowering Effect
    Tingting Chen, Anna B. Liu, Shili Sun, Nadim J. Ajami, Matthew C. Ross, Hong Wang, Le Zhang, Kenneth Reuhl, Koichi Kobayashi, Janet C. Onishi, Liping Zhao, Chung S. Yang
    Molecular Nutrition & Food Research.2019;[Epub]     CrossRef
  • Effect of herbal tea on glycemic control in patients with type 2 diabetes
    Boxun Zhang, Rensong Yue, Xiaoying Huang, Ying Wang, Yayi Jiang, Jiawei Chin
    Medicine.2019; 98(50): e18346.     CrossRef
  • Effects of polysaccharides and polyphenolics fractions of Zijuan tea (Camellia sinensis var. kitamura) on α‐glucosidase activity and blood glucose level and glucose tolerance of hyperglycaemic mice
    Dejing Chen, Jingyuan Sun, Weixue Dong, Yixiao Shen, Zhimin Xu
    International Journal of Food Science & Technology.2018; 53(10): 2335.     CrossRef
  • Green tea consumption reduces apelin and orexin-A in overweight and obese women with different training modalities
    Rahman Soori, Azadeh Safei, Parisa Pournemati, Amine Ghram
    Sport Sciences for Health.2018; 14(2): 421.     CrossRef
  • Green tea consumption and risk of type 2 diabetes in Chinese adults: the Shanghai Women’s Health Study and the Shanghai Men’s Health Study
    Xiaona Liu, Wanghong Xu, Hui Cai, Yu-Tang Gao, Honglan Li, Bu-Tian Ji, Xiang Shu, Thomas Wang, Robert E Gerszten, Wei Zheng, Yong-Bing Xiang, Xiao-Ou Shu
    International Journal of Epidemiology.2018; 47(6): 1887.     CrossRef
Obesity and Metabolic Syndrome
Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs
Beatriz Dal Santo Francisco Bonamichi, Jongsoon Lee
Diabetes Metab J. 2017;41(4):229-250.   Published online May 22, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.4.229
  • 5,407 View
  • 71 Download
  • 33 Web of Science
  • 37 Crossref
AbstractAbstract PDFPubReader   

The notion that obesity-induced inflammation mediates the development of insulin resistance in animal models and humans has been gaining strong support. It has also been shown that immune cells in local tissues, in particular in visceral adipose tissue, play a major role in the regulation of obesity-induced inflammation. Specifically, obesity increases the numbers and activation of proinflammatory immune cells, including M1 macrophages, neutrophils, Th1 CD4 T cells, and CD8 T cells, while simultaneously suppressing anti-inflammatory cells such as M2 macrophages, CD4 regulatory T cells, regulatory B cells, and eosinophils. Recently, however, new cell types have been shown to participate in the development of obesity-induced inflammation and insulin resistance. Some of these cell types also appear to regulate obesity. These cells are natural killer (NK) cells and innate lymphoid cells (ILCs), which are closely related, and invariant natural killer T (iNKT) cells. It should be noted that, although iNKT cells resemble NK cells in name, they are actually a completely different cell type in terms of their development and functions in immunity and metabolism. In this review, we will focus on the roles that these relatively new players in the metabolism field play in obesity-induced insulin resistance and the regulation of obesity.

Citations

Citations to this article as recorded by  
  • NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance
    Gracia Nathalie, Beatriz Dal Santo Francisco Bonamichi, Jieun Kim, Jiwon Jeong, Haneul Kang, Emirrio Reinaldie Hartland, Eveline Eveline, Jongsoon Lee
    Molecules and Cells.2024; 47(3): 100007.     CrossRef
  • Adipose tissue macrophage heterogeneity in the single-cell genomics era
    Haneul Kang, Jongsoon Lee
    Molecules and Cells.2024; 47(2): 100031.     CrossRef
  • Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
    Teresa Vilariño-García, María Polonio-González, Antonio Pérez-Pérez, Josep Ribalta, Francisco Arrieta, Manuel Aguilar, Juan Obaya, José Gimeno-Orna, Pedro Iglesias, Jorge Navarro, Santiago Durán, Juan Pedro-Botet, Víctor Sánchez-Margalet
    International Journal of Molecular Sciences.2024; 25(4): 2338.     CrossRef
  • TRP channels associated with macrophages as targets for the treatment of obese asthma
    Wenzhao Zhu, Dinxi Bai, Wenting Ji, Jing Gao
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Brief Report: Relationship Between Adiposity and Biomarkers of Aging and Frailty Among Adults Aging With HIV
    Vitor H. F. Oliveira, Amanda L. Willig, Christine Horvat Davey, Thomas W. Buford, Prema Menezes, Edward Cachay, Heidi M. Crane, Greer A. Burkholder, Barbara M. Gripshover, Julia G. Fleming, John D. Cleveland, Allison R. Webel
    JAIDS Journal of Acquired Immune Deficiency Syndromes.2024; 95(4): 377.     CrossRef
  • Causal association of obesity with epigenetic aging and telomere length: a bidirectional mendelian randomization study
    Jixin Li, Wenru Wang, Zhenyu Yang, Linjie Qiu, Yan Ren, Dongling Wang, Meijie Li, Wenjie Li, Feng Gao, Jin Zhang
    Lipids in Health and Disease.2024;[Epub]     CrossRef
  • Insights into the Roles of Natural Killer Cells in Osteoarthritis
    Chang-Qing Zheng, Ling-Jun Zeng, Zhi-Hong Liu, Chen-Fang Miao, Ling-Yan Yao, Hong-Tao Song, Xiao-Mu Hu, Xin Zhou
    Immunological Investigations.2024; : 1.     CrossRef
  • A 30‐color spectral flow cytometry panel for comprehensive analysis of immune cell composition and macrophage subsets in mouse metabolic organs
    Joost M. Lambooij, Tamar Tak, Arnaud Zaldumbide, Bruno Guigas
    Cytometry Part A.2024;[Epub]     CrossRef
  • Adipose tissue aging is regulated by an altered immune system
    Yi-Xiang Zhang, Min-Yi Ou, Zi-Han Yang, Yu Sun, Qing-Feng Li, Shuang-Bai Zhou
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • The Influence of Maternal Folate Status on Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
    Ruhan Xu, Shenhao Liu, Zhiqi Zhong, Yifei Guo, Tianqi Xia, Yanyan Chen, Lingling Ding
    Nutrients.2023; 15(12): 2766.     CrossRef
  • Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
    Qixiang Zhao, Jiayu Wu, Yong Ding, Yanli Pang, Changtao Jiang
    Life Metabolism.2023;[Epub]     CrossRef
  • Proteomic Analysis by 4D Label-free MS-PRM Provides Insight into the Role and Regulatory Mechanisms of IL-25 in NK Cells
    Juan Feng, Luoyao Huang, Shuaipeng Yang, Jiasheng Pan, Xiangxing Zhu, Dongsheng Tang
    Protein & Peptide Letters.2023; 30(10): 841.     CrossRef
  • No association of natural killer cell number and function in peripheral blood with overweight/obesity and metabolic syndrome in a cohort of young women
    Julia Keilen, Christina Gar, Marietta Rottenkolber, Louise U. Fueessl, Anna T. Joseph, Rika Draenert, Jochen Seissler, Andreas Lechner
    Physiological Reports.2022;[Epub]     CrossRef
  • Browning Epicardial Adipose Tissue: Friend or Foe?
    Elisa Doukbi, Astrid Soghomonian, Coralie Sengenès, Shaista Ahmed, Patricia Ancel, Anne Dutour, Bénédicte Gaborit
    Cells.2022; 11(6): 991.     CrossRef
  • Synthetic cannabinoid WIN 55,212–2 inhibits growth and induces cell death of oral and pancreatic stem-like/poorly differentiated tumor cells
    Meng-Wei Ko, Barbara Breznik, Emanuela Senjor, Anahid Jewett
    Advances in Cancer Biology - Metastasis.2022; 5: 100043.     CrossRef
  • Aldose reductase promotes diet‐induced obesity via induction of senescence in subcutaneous adipose tissue
    Devi Thiagarajan, Nosirudeen Quadri, Shabnam Jawahar, Hylde Zirpoli, Carmen Hurtado del Pozo, Raquel López‐Díez, Syed Nurul Hasan, Gautham Yepuri, Paul F. Gugger, Brian S. Finlin, Philip A. Kern, Kenneth Gabbay, Ann Marie Schmidt, Ravichandran Ramasamy
    Obesity.2022; 30(8): 1647.     CrossRef
  • Macrophages, Chronic Inflammation, and Insulin Resistance
    He Li, Ya Meng, Shuwang He, Xiaochuan Tan, Yujia Zhang, Xiuli Zhang, Lulu Wang, Wensheng Zheng
    Cells.2022; 11(19): 3001.     CrossRef
  • Ethnicity and the relationship between covid-19 and the herpes simplex viruses
    Peter Bond
    Medical Hypotheses.2021; 146: 110447.     CrossRef
  • Association between maternal folate status and gestational diabetes mellitus
    Yan Yang, Zixin Cai, Jingjing Zhang
    Food Science & Nutrition.2021; 9(4): 2042.     CrossRef
  • Natural Killer Cells: Friend or Foe in Metabolic Diseases?
    Yi Li, Fangjie Wang, Saber Imani, Ling Tao, Youcai Deng, Yue Cai
    Frontiers in Immunology.2021;[Epub]     CrossRef
  • Natural Killer Cells: Diverse Functions in Tumor Immunity and Defects in Pre-neoplastic and Neoplastic Stages of Tumorigenesis
    Anahid Jewett, Janko Kos, Kawaljit Kaur, Tahmineh Safaei, Christine Sutanto, Wuyang Chen, Paul Wong, Artin Keshishian Namagerdi, Changge Fang, Yuman Fong, Meng-Wei Ko
    Molecular Therapy - Oncolytics.2020; 16: 41.     CrossRef
  • NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production
    Junhua Wu, Danyang Wu, Longyao Zhang, Chuxuan Lin, Jiahao Liao, Ruyin Xie, Zhulin Li, Siyang Wu, Aimin Liu, Weining Hu, Yang Xi, Shizhong Bu, Fuyan Wang
    Journal of Leukocyte Biology.2020; 107(4): 589.     CrossRef
  • Concentration of NK cells after β-glucan and vitamin D supplementation in patients with diabetic retinopathy
    Richter Josef, Pohorska Jitka, Závorková Martina, Král Vlastimil, Stiborova Ivana, Dobiasova Rajnohova Lucie, Vetvicka Vaclav
    Folia Microbiologica.2020; 65(4): 755.     CrossRef
  • Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
    Mary Jane West-Eberhard
    Proceedings of the National Academy of Sciences.2019; 116(3): 723.     CrossRef
  • Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
    Mohammad Hosein Farzaei, Amit Kumar Singh, Ramesh Kumar, Courtney R. Croley, Abhay K. Pandey, Ericsson Coy-Barrera, Jayanta Kumar Patra, Gitishree Das, Rout George Kerry, Giuseppe Annunziata, Gian Carlo Tenore, Haroon Khan, Matteo Micucci, Roberta Budries
    International Journal of Molecular Sciences.2019; 20(19): 4957.     CrossRef
  • Correlations between Body Mass Index, Plasma High-Sensitivity C-Reactive Protein and Lipids in Patients with Schizophrenia
    Ted Boozalis, Sridevi Devaraj, Olaoluwa O. Okusaga
    Psychiatric Quarterly.2019; 90(1): 101.     CrossRef
  • Association of maternal folate status in the second trimester of pregnancy with the risk of gestational diabetes mellitus
    Kaipeng Xie, Pengfei Xu, Ziyi Fu, Xiaohong Gu, Hui Li, Xianwei Cui, Lianghui You, Lijun Zhu, Chenbo Ji, Xirong Guo
    Food Science & Nutrition.2019; 7(11): 3759.     CrossRef
  • An intracrine view of sex steroids, immunity, and metabolic regulation
    Katya B. Rubinow
    Molecular Metabolism.2018; 15: 92.     CrossRef
  • CD4+ T cells in obesity and obesity-associated diseases
    Yueshui Zhao, Ling Lin, Jing Li, Zhangang Xiao, Bo Chen, Lin Wan, Mingxing Li, Xu Wu, Chi Hin Cho, Jing Shen
    Cellular Immunology.2018; 332: 1.     CrossRef
  • Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
    Kawaljit Kaur, Milica Perišić Nanut, Meng-Wei Ko, Tahmineh Safaie, Janko Kos, Anahid Jewett
    Current Opinion in Immunology.2018; 51: 170.     CrossRef
  • Parallels in Immunometabolic Adipose Tissue Dysfunction with Ageing and Obesity
    William Trim, James E. Turner, Dylan Thompson
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • In response to Manuscript AJRI 01‐18‐016 entitled “Regulatory T cells, natural killer cells and obesity in patients with gestational diabetes mellitus”—Kawada T
    Thalita Frutuoso Lobo, Camila de Moraes Borges, Rosiane Mattar, Caio Perez Gomes, Ana Geisa Santos de Ângelo, Karen Piriscila Tezotto Pendeloski, Silvia Daher
    American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
  • Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis
    Robert J. van Eijkeren, Olga Krabbe, Marianne Boes, Henk S. Schipper, Eric Kalkhoven
    Immunology.2018; 153(2): 179.     CrossRef
  • Regulatory T cells, natural killer cells, and obesity in patients with gestational diabetes mellitus
    Tomoyuki Kawada
    American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
  • Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr−/− Mice
    Savitha Subramanian, Leela Goodspeed, Shari Wang, Yilei Ding, Kevin O’Brien, Godfrey Getz, Alan Chait, Catherine Reardon
    International Journal of Molecular Sciences.2018; 19(2): 510.     CrossRef
  • The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection
    Jordan E. Lake
    Current HIV/AIDS Reports.2017; 14(6): 211.     CrossRef
  • Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes
    Vivekanandhan Aravindhan, Gowrishankar Anand
    The American Journal of Tropical Medicine and Hygiene.2017; 97(6): 1650.     CrossRef
Clinical Care/Education
A Clinical Practice Guideline to Guide a System Approach to Diabetes Care in Hong Kong
Ip Tim Lau
Diabetes Metab J. 2017;41(2):81-88.   Published online April 14, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.2.81
  • 3,720 View
  • 54 Download
  • 33 Web of Science
  • 33 Crossref
AbstractAbstract PDFPubReader   

The Hospital Authority of Hong Kong is a statutory body that manages all the public medical care institutions in Hong Kong. There are currently around 400,000 diabetic patients under its care at 17 hospitals (providing secondary care for 40%) and 73 General Outpatient Clinics (providing primary care for 60%). The patient population has been growing at 6% to 8% per year over the past 5 years, estimated to include over 95% of all diagnosed patients in Hong Kong. In order to provide equitable and a minimal level of care within resources and local system factors constraints, a Clinical Practice Guideline on the management of type 2 diabetes mellitus was drawn in 2013 to guide a system approach to providing diabetes care. There is an algorithm for the use of various hypoglycemic agents. An organizational drug formulary governs that less expansive options have to be used first. A number of clinical care and patient empowerment programs have been set up to support structured and systematic diabetes care. With such a system approach, there have been overall improvements in diabetes care with the percentage of patients with glycosylated hemoglobin <7% rising from 40% in 2010 to 52% in 2015.

Citations

Citations to this article as recorded by  
  • Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program
    Kailu Wang, Shi Zhao, Eric Kam-Pui Lee, Susan Zi-May Yau, Yushan Wu, Chi-Tim Hung, Eng-Kiong Yeoh
    JAMA Network Open.2024; 7(2): e2355733.     CrossRef
  • Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
    Eric Yuk Fai Wan, Wanchun Xu, Anna Hoi Ying Mok, Weng Yee Chin, Esther Yee Tak Yu, Celine Sze Ling Chui, Esther Wai Yin Chan, Ian Chi Kei Wong, Cindy Lo Kuen Lam, Goodarz Danaei
    Diabetes, Obesity and Metabolism.2024; 26(5): 1877.     CrossRef
  • SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong
    Chi-Ho Lee, Lung-Yi Mak, Eric Ho-Man Tang, David Tak-Wai Lui, Jimmy Ho-Cheung Mak, Lanlan Li, Tingting Wu, Wing Lok Chan, Man-Fung Yuen, Karen Siu-Ling Lam, Carlos King Ho Wong
    Hepatology.2023; 78(5): 1569.     CrossRef
  • Team-Based Diabetes Care in Ontario and Hong Kong: a Comparative Review
    Calvin Ke, Emaad Mohammad, Juliana C. N. Chan, Alice P. S. Kong, Fok-Han Leung, Baiju R. Shah, Douglas Lee, Andrea O. Luk, Ronald C. W. Ma, Elaine Chow, Xiaolin Wei
    Current Diabetes Reports.2023; 23(7): 135.     CrossRef
  • Association of eGFR slope with all-cause mortality, macrovascular and microvascular outcomes in people with type 2 diabetes and early-stage chronic kidney disease
    Qiao Jin, Cindy Lo Kuen Lam, Eric Yuk Fai Wan
    Diabetes Research and Clinical Practice.2023; 205: 110924.     CrossRef
  • Association Between SGLT2 Inhibitors vs DPP-4 Inhibitors and Risk of Pneumonia Among Patients With Type 2 Diabetes
    Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, Ian C K Wong, Ying Wong, Ching-Lung Cheung
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(4): e1719.     CrossRef
  • Effectiveness of Integrative Chinese–Western Medicine for Chronic Kidney Disease and Diabetes: A Retrospective Cohort Study
    Kam Wa Chan, Tak Yee Chow, Kam Yan Yu, Yibin Feng, Lixing Lao, Zhaoxiang Bian, Vivian Taam Wong, Sydney Chi-Wai Tang
    The American Journal of Chinese Medicine.2022; 50(02): 371.     CrossRef
  • Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patients With Type 2 Diabetes
    Philip C M Au, Kathryn C B Tan, Bernard M Y Cheung, Ian C K Wong, Hang-Long Li, Ching-Lung Cheung
    The Journal of Clinical Endocrinology & Metabolism.2022; 107(7): e2962.     CrossRef
  • Association Between Team-Based Continuity of Care and Risk of Cardiovascular Diseases Among Patients With Diabetes: A Retrospective Cohort Study
    Kam Suen Chan, Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ivy Lynn Mak, Will Ho Gi Cheng, Margaret Kay Ho, Cindy Lo Kuen Lam
    Diabetes Care.2022; 45(5): 1162.     CrossRef
  • mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study
    Eric Yuk Fai Wan, Celine Sze Ling Chui, Anna Hoi Ying Mok, Wanchun Xu, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, David Tak Wai Lui, Kathryn Choon Beng Tan, Ivan Fan Ngai Hung, Cindy Lo Kuen Lam, Gabriel
    Drug Safety.2022; 45(12): 1477.     CrossRef
  • Evaluation of Fracture Risk Among Patients With Type 2 Diabetes and Nonvalvular Atrial Fibrillation Receiving Different Oral Anticoagulants
    David Tak Wai Lui, Eric Ho Man Tang, Ivan Chi Ho Au, Tingting Wu, Chi Ho Lee, Chun Ka Wong, Chloe Yu Yan Cheung, Carol Ho Yi Fong, Wing Sun Chow, Yu Cho Woo, Kathryn Choon Beng Tan, Karen Siu Ling Lam, Carlos King Ho Wong
    Diabetes Care.2022; 45(11): 2620.     CrossRef
  • Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study
    Eric Ho Man Tang, Ivy Lynn Mak, Emily Tsui Yee Tse, Eric Yuk Fai Wan, Esther Yee Tak Yu, Julie Yun Chen, Weng Yee Chin, David Vai Kiong Chao, Wendy Wing Sze Tsui, Tony King Hang Ha, Carlos King Ho Wong, Cindy Lo Kuen Lam
    Diabetes Care.2022; 45(12): 2871.     CrossRef
  • An Intervention to Change Illness Representations and Self-Care of Individuals With Type 2 Diabetes: A Randomized Controlled Trial
    Virginia W.Y. Chan, Alice P.S. Kong, Joseph T.F. Lau, Winnie W.S. Mak, Linda D. Cameron, Phoenix K.H. Mo
    Psychosomatic Medicine.2021; 83(1): 71.     CrossRef
  • Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study
    Joe Kwun Nam Chan, Corine Sau Man Wong, Philip Chi Fai Or, Eric Yu Hai Chen, Wing Chung Chang
    The British Journal of Psychiatry.2021; 219(1): 375.     CrossRef
  • Screening for diabetic retinopathy with different levels of financial incentive in a randomized controlled trial
    Jin Xiao Lian, Sarah Morag McGhee, Ching So, Alfred Siu Kei Kwong, Rita Sum, Wendy Wing Sze Tsui, David Vai Kiong Chao, Jonathan Cheuk Hung Chan
    Journal of Diabetes Investigation.2021; 12(9): 1632.     CrossRef
  • Greater variability in lipid measurements associated with kidney diseases in patients with type 2 diabetes mellitus in a 10-year diabetes cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Christie Sze Ting Lau, Anna Hoi Ying Mok, Yuan Wang, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Scientific Reports.2021;[Epub]     CrossRef
  • Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study
    Jianchao Quan, Carmen S. Ng, Harley H. Y. Kwok, Ada Zhang, Yuet H. Yuen, Cheung-Hei Choi, Shing-Chung Siu, Simon Y. Tang, Nelson M. Wat, Jean Woo, Karen Eggleston, Gabriel M. Leung, Weiping Jia
    PLOS Medicine.2021; 18(6): e1003692.     CrossRef
  • Age‐Specific Associations of Usual Blood Pressure Variability With Cardiovascular Disease and Mortality: 10‐Year Diabetes Mellitus Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Jessica K. Barrett, Ian Chi Kei Wong, Esther Wai Yin Chan, Celine Sze Ling Chui, Shiqi Chen, Cindy Lo Kuen Lam
    Journal of the American Heart Association.2021;[Epub]     CrossRef
  • Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up
    Joe Kwun Nam Chan, Corine Sau Man Wong, Philip Chi Fai Or, Eric Yu Hai Chen, Wing Chung Chang
    European Neuropsychopharmacology.2021; 53: 79.     CrossRef
  • Age‐specific associations of glycated haemoglobin variability with cardiovascular disease and mortality in patients with type 2 diabetes mellitus: A 10‐ year cohort study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Florence Ting Yan Ng, Shu Ming Cheryl Chia, Ian Chi Kei Wong, Esther Wai Yin Chan, Cindy Lo Kuen Lam
    Diabetes, Obesity and Metabolism.2020; 22(8): 1316.     CrossRef
  • The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study
    Eric Yuk Fai Wan, Weng Yee Chin, Esther Yee Tak Yu, Ian Chi Kei Wong, Esther Wai Yin Chan, Shirley Xue Li, Nico Kwan Lok Cheung, Yuan Wang, Cindy Lo Kuen Lam
    Diabetes Care.2020; 43(8): 1750.     CrossRef
  • Greater variability in lipid measurements associated with cardiovascular disease and mortality: A 10‐year diabetes cohort study
    Eric Y. F. Wan, Esther Y. T. Yu, Weng Y. Chin, Jessica K. Barrett, Anna H. Y. Mok, Christie S. T. Lau, Yuan Wang, Ian C. K. Wong, Esther W. Y. Chan, Cindy L. K. Lam
    Diabetes, Obesity and Metabolism.2020; 22(10): 1777.     CrossRef
  • Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: A population-based observational study
    Calvin Ke, Thérèse A. Stukel, Baiju R. Shah, Eric Lau, Ronald C. Ma, Wing-Yee So, Alice P. Kong, Elaine Chow, Juliana C. N. Chan, Andrea Luk, Sanjay Basu
    PLOS Medicine.2020; 17(9): e1003316.     CrossRef
  • Age‐Specific Associations Between Systolic Blood Pressure and Cardiovascular Disease: A 10‐Year Diabetes Mellitus Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Ian Chi Kei Wong, Esther Wai Yin Chan, Shiqi Chen, Cindy Lo Kuen Lam
    Journal of the American Heart Association.2020;[Epub]     CrossRef
  • Associations between usual glycated haemoglobin and cardiovascular disease in patients with type 2 diabetes mellitus: A 10‐year diabetes cohort study
    Eric YF Wan, Esther YT Yu, Julie Y Chen, Ian CK Wong, Esther WY Chan, Cindy LK Lam
    Diabetes, Obesity and Metabolism.2020; 22(12): 2325.     CrossRef
  • Cultural adaptation and psychometric properties of the Chinese Burden of Treatment Questionnaire (C-TBQ) in primary care patients with multi-morbidity
    Weng Yee Chin, Carlos King Ho Wong, Cherry Cheuk Wai Ng, Edmond Pui Hang Choi, Cindy Lo Kuen Lam
    Family Practice.2019; 36(5): 657.     CrossRef
  • Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Cindy Lo Kuen Lam
    Hypertension.2019; 74(2): 331.     CrossRef
  • Burden of CKD and Cardiovascular Disease on Life Expectancy and Health Service Utilization: a Cohort Study of Hong Kong Chinese Hypertensive Patients
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Eric Ho Man Tang, Cindy Lo Kuen Lam
    Journal of the American Society of Nephrology.2019; 30(10): 1991.     CrossRef
  • Effect of Achieved Systolic Blood Pressure on Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Population-Based Retrospective Cohort Study
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Weng Yee Chin, Colman Siu Cheung Fung, Daniel Yee Tak Fong, Edmond Pui Hang Choi, Anca Ka Chun Chan, Cindy Lo Kuen Lam
    Diabetes Care.2018; 41(6): 1134.     CrossRef
  • Evolution of Diabetes Care in Hong Kong: From the Hong Kong Diabetes Register to JADE-PEARL Program to RAMP and PEP Program
    Ivy H.Y. Ng, Kitty K.T. Cheung, Tiffany T.L. Yau, Elaine Chow, Risa Ozaki, Juliana C.N. Chan
    Endocrinology and Metabolism.2018; 33(1): 17.     CrossRef
  • Relation between HbA1c and incident cardiovascular disease over a period of 6 years in the Hong Kong population
    E.Y.F. Wan, E.Y.T. Yu, C.S.C. Fung, W.Y. Chin, D.Y.T. Fong, A.K.C. Chan, C.L.K. Lam
    Diabetes & Metabolism.2018; 44(5): 415.     CrossRef
  • Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
    Eric Yuk Fai Wan, Colman Siu Cheung Fung, Fang Fang Jiao, Esther Yee Tak Yu, Weng Yee Chin, Daniel Yee Tak Fong, Carlos King Ho Wong, Anca Ka Chun Chan, Karina Hiu Yen Chan, Ruby Lai Ping Kwok, Cindy Lo Kuen Lam
    Diabetes Care.2018; 41(1): 49.     CrossRef
  • Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Eric Yuk Fai Wan, Esther Yee Tak Yu, Colman Siu Cheung Fung, Weng Yee Chin, Daniel Yee Tak Fong, Anca Ka Chun Chan, Cindy Lo Kuen Lam
    Hypertension.2017; 70(6): 1273.     CrossRef
Pathophysiology
Nuclear Receptors Resolve Endoplasmic Reticulum Stress to Improve Hepatic Insulin Resistance
Jae Man Lee
Diabetes Metab J. 2017;41(1):10-19.   Published online February 16, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.1.10
  • 4,583 View
  • 94 Download
  • 13 Web of Science
  • 13 Crossref
AbstractAbstract PDFPubReader   

Chronic endoplasmic reticulum (ER) stress culminating in proteotoxicity contributes to the development of insulin resistance and progression to type 2 diabetes mellitus. Pharmacologic interventions targeting several different nuclear receptors have emerged as potential treatments for insulin resistance. The mechanistic basis for these antidiabetic effects has primarily been attributed to multiple metabolic and inflammatory functions. Here we review recent advances in our understanding of the association of ER stress with insulin resistance and the role of nuclear receptors in promoting ER stress resolution and improving insulin resistance in the liver.

Citations

Citations to this article as recorded by  
  • Duality of Nrf2 in iron-overload cardiomyopathy
    Enrica Federti, Francesca Vinchi, Iana Iatcenko, Alessandra Ghigo, Alessandro Matte, Serge Cedrick Mbiandjeu Toya, Angela Siciliano, Deborah Chiabrando, Emanuela Tolosano, Steven Zebulon Vance, Veronica Riccardi, Immacolata Andolfo, Manuela Iezzi, Alessia
    Haematologica.2023; 108(5): 1335.     CrossRef
  • Endoplasmic Reticulum Stress and Its Impact on Adipogenesis: Molecular Mechanisms Implicated
    Gyuhui Kim, Jiyoon Lee, Joohun Ha, Insug Kang, Wonchae Choe
    Nutrients.2023; 15(24): 5082.     CrossRef
  • Qingluotongbi formula regulates the LXRα-ERS-SREBP-1c pathway in hepatocytes to alleviate the liver injury caused by Tripterygium wilfordii Hook. f.
    Zhichao Yu, Zhe Feng, Ling Fu, Jing Wang, Changqing Li, Huaxu Zhu, Tong Xie, Jie Zhou, Lingling Zhou, Xueping Zhou
    Journal of Ethnopharmacology.2022; 287: 114952.     CrossRef
  • Nuclear‐mitochondrial crosstalk: On the role of the nuclear receptor liver receptor homolog‐1 (NR5A2) in the regulation of mitochondrial metabolism, cell survival, and cancer
    Svenja Michalek, Thomas Brunner
    IUBMB Life.2021; 73(3): 592.     CrossRef
  • NGBR is required to ameliorate type 2 diabetes in mice by enhancing insulin sensitivity
    Yi Chen, Wenquan Hu, Qi Li, Shiwei Zhao, Dan Zhao, Shuang Zhang, Zhuo Wei, Xiaoxiao Yang, Yuanli Chen, Xiaoju Li, Chenzhong Liao, Jihong Han, Qing Robert Miao, Yajun Duan
    Journal of Biological Chemistry.2021; 296: 100624.     CrossRef
  • Impaired ferritinophagy flux induced by high fat diet mediates hepatic insulin resistance via endoplasmic reticulum stress
    Chunjie Jiang, Shanshan Zhang, Dan Li, Li Chen, Ying Zhao, Guibin Mei, Jingjing Liu, Yuhan Tang, Chao Gao, Ping Yao
    Food and Chemical Toxicology.2020; 140: 111329.     CrossRef
  • Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
    Minyoung Lee, Eugene Shin, Jaehyun Bae, Yongin Cho, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
    Scientific Reports.2020;[Epub]     CrossRef
  • Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study
    Nam Hoon Kim, Ki Hoon Han, Jimi Choi, Juneyoung Lee, Sin Gon Kim
    BMJ.2019; : l5125.     CrossRef
  • Inhibition of the Low Molecular Weight Protein Tyrosine Phosphatase (LMPTP) as a Potential Therapeutic Strategy for Hepatic Progenitor Cells Lipotoxicity—Short Communication
    Michalina Alicka, Katarzyna Kornicka-Garbowska, Michael Roecken, Krzysztof Marycz
    International Journal of Molecular Sciences.2019; 20(23): 5873.     CrossRef
  • Myricetin prevents thapsigargin-induced CDK5-P66Shc signalosome mediated pancreatic β-cell dysfunction
    Udayakumar Karunakaran, Ji Eun Lee, Suma Elumalai, Jun Sung Moon, Kyu Chang Won
    Free Radical Biology and Medicine.2019; 141: 59.     CrossRef
  • Spontaneous ketonuria and risk of incident diabetes: a 12 year prospective study
    Gyuri Kim, Sang-Guk Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Ele Ferrannini, Yong-ho Lee, Nam H. Cho
    Diabetologia.2019; 62(5): 779.     CrossRef
  • CCAAT/enhancer binding protein homologous protein knockdown alleviates hypoxia-induced myocardial injury in rat cardiomyocytes exposed to high glucose
    Wenqi Yang, Fang Wu, Ting Luo, Yuelan Zhang
    Experimental and Therapeutic Medicine.2018;[Epub]     CrossRef
  • Association of changes in ER stress-mediated signaling pathway with lead-induced insulin resistance and apoptosis in rats and their prevention by A-type dimeric epigallocatechin-3-gallate
    Chan-Min Liu, Jie-Qiong Ma, Jian-Mei Sun, Zhao-Jun Feng, Chao Cheng, Wei Yang, Hong Jiang
    Food and Chemical Toxicology.2017; 110: 325.     CrossRef
Obesity and Metabolic Syndrome
Diabetes Prevention in Australia: 10 Years Results and Experience
James A. Dunbar
Diabetes Metab J. 2017;41(3):160-167.   Published online February 2, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.3.160
  • 4,859 View
  • 69 Download
  • 12 Web of Science
  • 11 Crossref
AbstractAbstract PDFPubReader   

Clinical trials have demonstrated the efficacy of lifestyle modification for the prevention of type 2 diabetes mellitus but it was achieved at higher cost than can be sustained in routine health services. The first clinical trial to report was the Finnish Diabetes Prevention Study. This paper describes how Australia worked with Finnish colleagues to adapt the findings of that study to achieve a statewide diabetes prevention program. Small evaluative, effectiveness trials have been conducted in a number of countries to see if the results of the clinical trials can be replicated in routine health services. The Australian evaluative trial, Greater Green Triangle Diabetes Prevention Program is described in detail to demonstrate the ingredients for success in moving a program from one country to another. Few countries have managed to scale up from evaluative trials to statewide or national programs. The Australian experience is described in detail including lessons learned about what reduced the effectiveness, particularly the need for policy makers in government, people from the implementing organisation and researchers to work together from the start of the evaluative trial and throughout the first 5 years of a national program.

Citations

Citations to this article as recorded by  
  • Miscarriage, stillbirth and the risk of diabetes in women: A systematic review and meta-analysis
    Qiqi You, Qingqing Jiang, Irakoze Shani, Yiling Lou, Shen Huang, Shiqi Wang, Shiyi Cao
    Diabetes Research and Clinical Practice.2023; 195: 110224.     CrossRef
  • A multiple case study of pre-diabetes care undertaken by general practice in Aotearoa/New Zealand: de-incentivised and de-prioritised work
    Christine Barthow, Jeremy Krebs, Eileen McKinlay
    BMC Primary Care.2023;[Epub]     CrossRef
  • Implementation of a diabetes prevention programme in a multi-ethnic community in primary care in England: An evaluation using constructs from the RE-AIM Framework
    Helen Dallosso, Kamlesh Khunti, Laura J. Gray, Kerry Hulley, Mel Ghaly, Naina Patel, Joe Kai, Navneet Aujla, Melanie J. Davies, Tom Yates
    Primary Care Diabetes.2023; 17(4): 309.     CrossRef
  • A critical realist exploration of factors influencing engagement in diabetes prevention programs in rural settings
    Britney McMullen, Kerith Duncanson, David Schmidt, Clare Collins, Lesley MacDonald-Wicks
    Australian Journal of Primary Health.2023; 29(5): 510.     CrossRef
  • Characteristics of participants in the first fully online National Diabetes Prevention Programme: A quantitative survey
    Clair Haseldine, Gráinne O'Donoghue, Patricia M Kearney, Fiona Riordan, Margaret Humphreys, Liz Kirby, Sheena McHugh
    HRB Open Research.2023; 6: 61.     CrossRef
  • Delivering the Diabetes Remission Clinical Trial (DiRECT) in primary care: Experiences of healthcare professionals
    Lucia Rehackova, Roy Taylor, Mike Lean, Alison Barnes, Louise McCombie, George Thom, Naomi Brosnahan, Wilma S. Leslie, Falko F. Sniehotta
    Diabetic Medicine.2022;[Epub]     CrossRef
  • It is time for a more targeted approach to prediabetes in primary care in Aotearoa New Zealand
    Christine Barthow, Sue Pullon, Eileen McKinlay, Jeremy Krebs, Stokes Tim
    Journal of Primary Health Care.2022; 14(4): 372.     CrossRef
  • Implementing a national diabetes prevention programme in England: lessons learned
    Jonathan Stokes, Judith Gellatly, Peter Bower, Rachel Meacock, Sarah Cotterill, Matt Sutton, Paul Wilson
    BMC Health Services Research.2019;[Epub]     CrossRef
  • How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing?
    J. Fagg, J. Valabhji
    Diabetic Medicine.2019; 36(3): 316.     CrossRef
  • Associations between physical activity and cataract treated surgically in patients with diabetes: findings from the 45 and Up Study
    Changfan Wu, Xiaotong Han, Xixi Yan, Xianwen Shang, Lei Zhang, Mingguang He
    British Journal of Ophthalmology.2019; 103(8): 1099.     CrossRef
  • Usefulness of a Novel Mobile Diabetes Prevention Program Delivery Platform With Human Coaching: 65-Week Observational Follow-Up
    Andreas Michaelides, Jennifer Major, Edmund Pienkosz Jr, Meghan Wood, Youngin Kim, Tatiana Toro-Ramos
    JMIR mHealth and uHealth.2018; 6(5): e93.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal